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Abstract 
This study examined factorial invariance of three self-report measures of psychiatric 
symptoms—the World Health Organization Adult ADHD Self-Report Scale (ASRS; Kessler et 
al., 2005), the Center for Epidemiologic Studies Depression Scale-Revised (CESD-R; Eaton, 
Smith, Ybarra, Muntaner, & Tien, 2004), and the Depression Anxiety Stress Scales (DASS; 
Lovibond & Lovibond, 1995)—using a convenience sample of 434 adults surveyed though 
Amazon Mechanical Turk. Participants were sorted into two groups based on their score on the 
Autism-Spectrum Quotient (AQ; Baron-Cohen, Wheelwright, Skinner, Martin, & Clubley, 
2001). Of 423 participants included in the final sample, 203 were included in the low ASD traits 
group and 220 were included in the high ASD traits group. Results indicated that the CESD-R 
did not demonstrate configural invariance, such that the same latent constructs did not emerge 
across both the low ASD traits and high ASD traits groups. Further, the CESD-R did not possess 
the same factor model specifications as previously established in general and clinical adult 
populations. The DASS-21 demonstrated evidence of scalar invariance, indicating cross-group 
equality in factor loadings and factor intercepts. The ASRS demonstrated evidence of metric 
invariance in the current sample, indicating that the established latent factors were represented in 
the data but that the levels and relations among those factors differed across groups. Findings 
from this study demonstrate that the DASS-21 and the CESD-R are not fully invariant across 
those with and without a high level of ASD traits, such that scores on these measures may not be 
valid when assessing symptoms of depression and anxiety in the ASD population. 
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Factor Invariance of Anxiety and Depression Measures in Autism 
 Autism spectrum disorder (ASD) is a neurodevelopmental disorder marked by deficits in 
social communication and social interaction, as well as the presence of repeated, restricted 
patterns of behavior, interests, or activities (American Psychiatric Association, 2013). 
Impairment in social communication and interaction may include deficits in social-emotional 
reciprocity, nonverbal communicative behaviors used for social interaction, or understanding and 
establishing social relationships. As its name implies, ASD is a heterogeneous construct that is 
thought to exist on a continuum, such that the phenotype can be conceptualized as a set of 
continuous traits that exist in the general population (Sucksmith, Roth, & Hoekstra, 2011), with 
people with a diagnosis of ASD scoring at the extreme end of this distribution (Baron-Cohen, 
2010). Previous research has indicated that the component traits of the autism spectrum are 
distributed across the population and potentially have distinct etiologies (Robinson et al., 2016; 
Bralten et al., 2017).  
 In 2014, the overall prevalence of ASD was 16.8 per 1,000 (one in 59) children aged 8 
years, with males four times more likely than females to be identified with ASD (Autism and 
Developmental Disabilities Monitoring [ADDM] Network, 2018). ASD prevalence estimates 
increased from 6.7 to 16.8 per 1,000 children aged 8 years, an increase of approximately 150 
percent, from 2000 to 2014 (ADDM Network, 2018). It remains unclear whether this increase is 
reflective of a true increase in prevalence or increased awareness of ASD and changes in 
diagnostic practices (Maenner et al., 2014). Regardless of which factors are driving this increase 
in prevalence, it remains the case that increasing numbers of children will be diagnosed with 
ASD, and that more individuals with ASD are entering the educational, medical, and community 
systems than ever before. This increase in the number of individuals entering these systems 
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warrants research into effective and evidence-based practices in each of these settings. 
Heretofore, common measures of adult outcome, including educational attainment, employment 
status, physical and mental health status, and quality of life have been poor for the population of 
individuals with ASD (Billstedt, Gillberg, & Gillberg, 2011; Farley, Cottle, Bilder, Viskochil, 
Coon, & McMahon, 2018; Howlin & Moss, 2012; Howlin, 2000). As a result, individuals with 
ASD may be underestimated, despite their skills and capabilities (Courchesne, Meilleur, Poulin-
Lord, Dawson, & Soulieres, 2015). 
The Stakeholder Perspective 
 In 2015, federal and private foundation funding for autism research in the United States 
exceeded $342 million (Office of Autism Research Coordination, National Institute of Mental 
Health, on behalf of the Interagency Autism Coordinating Committee, 2017). Recent research 
has indicated that this funding often does not match the needs and priorities of the autism 
community itself (Pellicano, Dinsmore, & Charman, 2014). Gotham et al. (2015) used online 
survey data from a large sample of adults with ASD and their legal guardians to investigate 
outcomes across a variety of contexts, as well as stakeholders’ priorities for future research. 
Areas of poorest adult outcome were associated with co-occurring physical and mental health 
conditions, vocational engagement, and low levels of adaptive behavior. In fitting with these 
outcomes, stakeholders indicated a need for more ASD research focused on life skills, 
treatments, co-occurring mental and emotional health conditions, and vocational and educational 
opportunities. Similarly, stakeholders and members of the ASD community based in the United 
Kingdom identified research focused on effective public services and evidence-based 
interventions as a priority (Pellicano, Dinsmore, & Charman, 2014).  
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 Co-occurring mental health conditions pose particular concern, given that traditional 
diagnostic measures have largely not been tested for validity and reliability in ASD populations 
(Leyfer et al., 2006). In keeping with the aforementioned ASD stakeholder priorities for 
research, the present study seeks to examine anxiety and depression in ASD, with particular 
focus on whether these constructs are measured reliably and validly in this population using 
common self-report instruments originally normed in the general population. Anxiety and 
depression may be difficult to assess in individuals with ASD, given that their presentation may 
be atypical or complicated by the social and communicative impairments inherent to autism 
(Stewart, Barnard, Pearson, Hasan, & O’Brien, 2006). The phenotypic overlap between these 
conditions and ASD, as well as the tendency for ASD symptomatology to mask anxiety and 
depression symptoms (Magnuson & Constantino, 2011), makes the psychometric examination of 
existing self-report measures in individuals with ASD an empirical question of importance.  
Comorbidity in ASD 
 ASD commonly co-occurs with other developmental, neurological, psychiatric, and 
genetic diagnoses (Gurney, McPheeters, & Davis, 2006; Matson & Nebel-Schwalm, 2007). In a 
population-based cohort of 2,568 eight-year-old children meeting surveillance case criteria for 
ASD, the co-occurrence of one or more non-ASD developmental diagnoses was 83 percent, and 
the co-occurrence of one or more psychiatric diagnoses was 10 percent (Levy et al., 2010). 
Children with ASD have been found to have significantly higher levels of psychopathology as 
compared to children with intellectual disability (Brereton, Tonge, & Einfeld, 2006). Still, age 
and intellectual functioning may be important factors to consider with regard to comorbidity in 
the population of adults with ASD. In a study of adults with ASD and intellectual disability, 
Totsika, Felce, Kerr, and Hastings (2010) found that psychiatric disorders were less frequent in 
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older adults with ASD and those with an intellectual disability compared to younger adults with 
co-occurring ASD and intellectual disability. Conversely, Roy, Prox-Vagedes, Ohlmeier, and 
Dillo (2015) found co-occurring psychiatric disorders to be more common in older adults with 
ASD without intellectual disability as compared to younger adults. On the other hand, a long-
term follow-up study of 58 adults with autism found that informant ratings of poor mental health 
were not associated with child or adult IQ or age (Moss, Howlin, Savage, Bolton, & Rutter, 
2015). These inconclusive findings point to the need for further research into potential mediators 
and moderators of the occurrence of psychiatric comorbidity in this population. 
Several studies have found high rates of depression and anxiety in individuals with ASD 
(Buck et al., 2014; Cassidy et al., 2014; Hofvander et al., 2009; Lugnegard, Hallerback, & 
Gillberg, 2011), with rates that are greater than that seen in the general population (Croen et al., 
2015; Joshi et al., 2013; Wigham, Barton, Parr, & Rodgers, 2017). Estimates taken from 
systematic reviews suggest that up to 60 percent of adults with ASD meet criteria for an anxiety 
disorder (Croen et al., 2015; Joshi et al., 2013; Uljarevic et al., 2018), rates which exceed those 
found in Down syndrome (Evans, Canavera, Klinepeter, Taga, & Maccubbin, 2005), specific 
language impairment (Gillott, Furniss, & Walter, 2001), and Williams syndrome (Rodgers, Riby, 
Janes, Connolly, & McConachie, 2012). Similarly, rates of depression in adults with ASD have 
been estimated to be as high as 50 to 70 percent (Lugnegard, Hallerback, & Gillberg, 2011; 
Wigham et al., 2017). A recent meta-analysis of the prevalence of depressive disorders in 
children, adolescents, and adults with ASD by Hudson, Hall, and Harkness (2018) found that the 
pooled lifetime prevalence rate was 14.4 percent and the pooled current prevalence rate was 12.3 
percent. Further, results indicated that individuals with ASD are four times more likely to 
experience depression in their lifetime compared to typically developing individuals (Hudson, 
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Hall, & Harkness, 2018). Overall, the extant literature demonstrates that a majority of adults with 
ASD meet diagnostic criteria for at least one psychiatric condition, with anxiety and depression 
being the most commonly co-occurring psychiatric disorders in adults with ASD after attention-
deficit/hyperactivity disorder (Lever & Geurts, 2016). 
Attention-Deficit/Hyperactivity Disorder 
 Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder 
defined by age-inappropriate inattention, impulsivity, and hyperactivity (American Psychiatric 
Association, 2013). For a diagnosis of ADHD to be made, significant symptoms must have onset 
prior to age 12, be currently manifested in two or more settings, and reduce the individual’s 
functioning. Alternative explanations for ADHD symptoms, including the presence of anxiety or 
mood disorders, must be excluded for the diagnosis to be given (Adler, Faraone, Sarocco, 
Atkins, & Khachatryan, 2019). Importantly, between 25 and 35 percent of children with ADHD 
are also likely to meet criteria for major depression or an anxiety disorder (Biederman et al., 
2008; Carlson, Tamm, & Gaub, 1997; Pliszka, 2007). Adult ADHD is one of the most commonly 
occurring disorders in the general population, with an estimated point prevalence of 4.4 percent, 
and is highly comorbid with other psychiatric disorders (Kessler et al., 2005). 
 ADHD and ASD show a high degree of comorbidity, with 22 to 83 percent of children 
with ASD having symptoms that satisfy criteria for ADHD (Ronald et al., 2008; Matson et al., 
2013), and an estimated 30 to 65 percent of children with ADHD having clinically significant 
symptoms of ASD (Clark et al., 1999; Ronald et al., 2008). Despite this high comorbidity, 
previous studies have indicated that children with ASD can be distinguished from children with 
ADHD based upon symptom profiles (Luteijn et al., 2000; Hattori, Ogino, Abiru, Nakano, Oka, 
& Ohtsuka, 2006; Mayes, Calhoun, Mayes, & Molitoris, 2012), with meaningful behavioral 
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differences between groups in terms of nonverbal communication, sensory interests, repetitive 
movements, and preoccupations. 
Comorbidity of Depression and Anxiety 
Depression and anxiety are known to be highly co-occurring conditions in the general 
population (Mineka et al., 1998; Moffit et al., 2007). Moreover, research has consistently found 
high correlations between depression and anxiety when measured on a continuum (Cannon & 
Weems, 2006; Morgan, Wiederman, & Magnus, 1998). Subsequently, some have suggested that 
the two may be merely differing expressions of the same underlying phenomenology (Burns & 
Eidelson, 1998; Feldman, 1993). Specifically, it has been posited that depression and anxiety 
may share the same diathesis (Barlow & Campbell, 2000; Clark & Watson, 1991). 
Notwithstanding these high correlations, depression and anxiety can be reliably distinguished 
from one another, with unique diagnostic aspects for each disorder (Beesdo, Pine, Lieb, & 
Wittchen, 2010). For instance, the tripartite model, a common theory that seeks to explain the 
common factors underlying anxiety and depression (Clark & Watson, 1991), posits that both 
anxiety and depression share elements related to negative affect; however, anhedonia is unique to 
depression, whereas physiologic arousal is unique to anxiety. Therefore, although both share 
elements of internalizing behavior, depression and anxiety can be measured as unique constructs.  
Anxiety 
Anxiety disorders are the most common mental health diagnosis in the United States, 
affecting nearly one in five American adults age 18 and older (US Department of Health and 
Human Services, 2016). Based on diagnostic interview data from the National Comorbidity 
Study Replication (NCS-R), an estimated 19.1 percent of adults in the United States had any 
anxiety disorder in the past year, and 31.1 percent experience any anxiety disorder at some point 
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in their lives (Harvard Medical School, 2007). Anxiety disorders are characterized by features of 
excessive anxiety and related behavioral disturbances, which cause clinically significant distress 
in social, academic, occupational, or other areas of functioning (American Psychiatric 
Association, 2013). High prevalence of anxiety disorders has been linked to low levels of 
education, low income, and unemployment (Michael, Zetsche, & Margraf, 2007). Anxiety also 
has a considerable impact on society in terms of decreased work productivity and increased 
health care utilization (Wittchen, 2002). The annual cost of anxiety disorders was estimated at 
$42 to $47 billion in the United States in 1990 (Greenberg et al., 1999; Rice & Miller, 1998). 
Consequently, anxiety disorders can have a measurable impact, both in a personal and in a 
societal sense. 
Depression 
The World Health Organization has recognized depression as the leading cause of 
disability worldwide, ranking as the single largest contributor to non-fatal health loss (World 
Health Organization [WHO], 2017). The 2016 National Survey on Drug Use and Health 
(NSDUH; Center for Behavioral Health Statistics and Quality, 2017) indicated that an estimated 
16.2 million adults in the United States had at least one major depressive episode, representing 
6.7 percent of all adults in the United States. Depressive disorders are characterized by sadness, 
loss of interest or pleasure, feelings of guilt or low self-worth, disturbed sleep or appetite, and 
poor concentration (American Psychiatric Association, 2013). Depression can be long lasting or 
recurrent, and thus can substantially impair an individual’s ability to function in daily life (WHO, 
2017). Depression is associated with higher rates of chronic disease and increased health care 
utilization (Katon, 2003; Wells et al., 1989). Most individuals with major depressive disorder 
report some sort of role impairment associated with their depression, including impairment in 
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home, work, relationship, and social domains (Kessler et al., 2003). Depression may have an 
adverse effect on health habits such as smoking, diet, overeating, and having a sedentary 
lifestyle, thus contributing to the incidence of additional medical conditions (Goodman & 
Whittaker, 2002; Rosal et al., 2001). Indeed, evidence suggests that both depressive symptoms 
and major depression may be associated with increased morbidity and mortality from illnesses 
such as diabetes and heart disease (Katon, 2003).  
Depression is also one of the largest contributors to suicide (Arsenault-Lapierre, Kim, & 
Turecki, 2004; Bradvik, Mattisson, Bogren, & Nettelbladt, 2010; Lonnqvist, 2000). Suicide was 
the tenth leading cause of death overall in the United States in 2016, claiming the lives of nearly 
45,000 people (National Center for Injury Prevention and Control, 2016). Given the high burden 
of disease inherent to depression, the US Preventive Services Task Force has recommended 
screening for depression in the general adult population, given that systems are in place to ensure 
accurate diagnosis, treatment, and follow-up (Siu et al., 2016). As follows from these 
recommendations, it is imperative that these systems are effective and available; however, the 
extant literature indicates that substantial gaps persist in the treatment of depression, with a 
majority of United States adults who screened positive for depression not having received 
treatment (Olfson, Blanco, & Marcus, 2016).  
Anxiety and Depression in ASD 
Several symptoms of ASD may share features with symptoms of depression and anxiety 
disorders. For instance, social avoidance and withdrawal, commonly seen in individuals with 
anxiety, may also be an expression of the social communication impairments that are common to 
ASD (Uljarevic et al., 2018). Similarly, common symptoms of depression, such as reduced eye 
contact and decreased communication of affect through facial expression or intonation, may be 
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masked by existing symptoms of ASD (Stewart, Barnard, Pearson, Hasan, & O’Brien, 2006). It 
is also possible that the converse is true, in that social affect-related symptoms of depression may 
mask underlying symptoms of ASD, though this hypothesis remains untested. These similarities 
in clinical presentation may make anxiety and depression more difficult to detect in this 
population. Ghaziuddin, Ghaziuddin, and Greden (2002) point out that diagnosing depression 
can be particularly difficult in individuals with severe cognitive or communication impairments, 
given that the diagnosis of depression often relies on the ability to recognize one’s own 
emotional state and to verbally express that emotional state. Recognition and expression of one’s 
emotional state poses challenges for many individuals with autism, some of whom may have 
difficulty inferring the mental or emotional states of others or even themselves (Baron-Cohen, 
1991; Mazefsky & Oswald, 2007). Because assessment of anxiety and depression is often reliant 
on self-report, this may present additional complications in those with limited insight or verbal 
aptitude. In such cases, attention to behavioral changes or informant reports may be helpful. For 
instance, increased aggression, self-injurious behavior, and irritability, as well as decreased self-
care, sleep difficulties, or weight changes have been noted in the onset of depression in 
individuals with ASD (Magnuson & Constantino, 2011). Similarly, an increase in repetitive or 
compulsive behaviors or reactions to sensory stimuli may be associated with anxiety disorders in 
those with ASD (Rodgers et al., 2016). Nonetheless, it remains largely unknown to what extent 
these behaviors are a direct result of the underlying mood or anxiety disorder. 
On the other hand, symptoms of ASD may contribute to the incidence of depression and 
anxiety. For instance, the social difficulties inherent to ASD may result in elevated loneliness 
and social isolation (Bauminger & Kasari, 2000; White & Roberson-Nay, 2009), both of which 
have been shown to predict depression among typically developing adults (Cacioppo, Hughes, 
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Waite, Hawkley, & Thisted, 2006). This relationship is not specific to typical development, as 
other research has supported the link between negative affect and the poor quality of social 
relationships in ASD (Whitehouse, Durkin, Jaquet, & Ziatas, 2009). Similarly, it is possible that 
associated characteristics of ASD, such as social skill deficits or sensory sensitivities, contribute 
or predispose to anxiety in this population (Bejerot, Eriksson, & Mortberg, 2014; Ben-Sasson et 
al., 2008; Farrugia & Hudson, 2006). Indeed, in his original description of autism, Leo Kanner 
(1943) hypothesized that the restricted and repetitive behavior of the children could be driven by 
anxiety. Others have suggested that ASD may increase vulnerability to anxiety as a result of the 
increased life stressors experienced by those with ASD (Gillott & Standen, 2007), as well as 
difficulties regulating emotion and arousal that are common in this population (Bellini, 2006). 
Importantly, however, it remains unknown to what extent anxiety results from ASD 
symptomatology, accompanies it, or arises from an alternate pathway (Kerns & Kendall, 2012). 
Kerns et al. (2014) assessed traditional and atypical presentations of anxiety in youth with 
ASD. With regard to atypical anxiety, individuals with ASD may exhibit anxiety that is 
associated with the characteristic features of ASD, such as excessive worry about circumscribed 
topics, including changes in schedule or the environment, or fears focused on perseverative or 
restricted behaviors, such as keeping sleeves rolled down or eating food of only one color (Kerns 
et al., 2014). Traditional anxiety disorders were found in 17 percent of their sample, whereas 
atypical anxiety was found in 15 percent of the sample; 31 percent of the sample presented with 
both traditional and atypical anxiety. The authors’ findings confirm the idea that anxiety is a true 
comorbidity among individuals with ASD, in that many co-occurring anxiety symptoms 
appeared to be distinct from associated features of ASD such as compulsions and social 
avoidance, thus providing support for the idea that some of these symptoms may reflect a distinct 
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manifestation of anxiety in ASD. However, Kerns et al. (2014) note that a definitive answer 
regarding the co-occurrence of anxiety and ASD is not possible, as there is a lack of validated 
diagnostic instruments with which to make these conclusions. 
Validity and Reliability of Measurement Instruments  
Research on the validity and reliability of standardized measures of anxiety and 
depression within the ASD population is limited, with few studies undertaking analyses of these 
constructs in a non-neurotypical sample. One cannot assume to measure a phenomenon of 
interest in a particular group accurately if measures have not been normed using members of that 
group, as this may pose a threat to validity and thus hinder the utility of that assessment (Hays & 
Wood, 2017).  
Validity refers to the degree to which an instrument measures the construct it purports to 
measure (Mokkink et al., 2010b). Validity can be further delineated into content validity, 
construct validity, and criterion validity. Content validity refers to the degree to which the items 
of the instrument adequately reflect the construct to be measured (Scholtes, Terwee, & Poolman, 
2011). Construct validity estimates the degree to which scores on an instrument are consistent 
with hypotheses, such as those regarding the relationships to other instruments of similar 
constructs (convergent validity) or instruments of dissimilar constructs (discriminant validity), as 
well as differences between relevant groups (Mokkink et al., 2010b). Finally, criterion validity 
refers to the strength of the relationship between measures intended to predict an ultimate 
criterion of interest and the criterion measure itself (Salkind, 2010). Relatedly, reliability can be 
defined as the degree to which an instrument is free from measurement error, or the consistency 
of scores from one assessment to another (Scholtes, Terwee, & Poolman, 2011). In this manner, 
reliability is a necessary, although not sufficient, component of validity, in that an instrument 
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that does not yield reliable scores cannot yield valid interpretations (Cook & Beckman, 2006). 
Internal consistency is a specific type of reliability, which assesses the degree of interrelatedness 
amongst individual items (Mokkink et al., 2010b). Subsequently, internal consistency assumes 
that items are part of one underlying construct (Scholtes, Terwee, & Poolman, 2011). In other 
words, internal consistency can be defined as the extent to which all the items of an instrument 
measure the same construct (Tang, Cui, & Babkeno, 2014).  
Measurement of Anxiety and Depression in Individuals with ASD 
There is a need to examine whether and to what degree common measures of anxiety and 
depression are able to assess these same constructs in individuals with ASD, in order to establish 
the reliability and validity of these measures in the ASD population. Several studies have 
examined the psychometric properties of such measures in children with ASD, with relatively 
fewer studies examining these constructs in adults with ASD.  
Sterling et al. (2015) examined the Revised Children’s Anxiety and Depression Scale 
(RCDAS; Chorpita et al., 2005) in a sample of 67 youth with autism spectrum disorders ranging 
in age from 11 to 15 years who also met criteria for an anxiety disorder. In addition to the 
RCDAS, other standardized measures of anxiety and depression, including the Anxiety 
Disorders Interview Schedule (ADIS-IV-C/P; Silverman & Albano, 1996), Child Behavior 
Checklist (CBCL; Achenbach, 2001), Multidimensional Anxiety Scale for Children—Parent 
(MASC-P; March, 1997), and the Pediatric Anxiety Rating Scale (PARS; Research Units on 
Pediatric Psychopharmacology Anxiety Study Group, 2002), were examined. Internal 
consistency of the RCADS was acceptable, with Cronbach’s alpha ranging from .72 to .93. To 
measure concurrent validity of the RCADS Total Anxiety and Total Internalizing scores, 
correlations were conducted with total scores on the ADIS, CBCL, MASC-P, and the PARS. 
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Total scores on the RCADS correlated with PARS total scores and with the CBCL 
Anxiety/Depression scale, indicating that the RCADS could potentially be a useful tool for self-
report of anxiety and depression among youth with ASD. To examine divergent validity, 
correlations were examined between RCADS Total scores and subscales of the CBCL and the 
Autism Diagnostic Observation Schedule (ADOS; Lord et al., 2002) that were not expected to be 
related. None of the relationships was significant, with the exception of the Attention Problems 
subscale of the CBCL, which had significant correlations with both the RCADS Total Anxiety 
and Total Internalizing scores, which the authors posit may be a result of the role of attention in 
regulating emotional impulses. Overall, results of Sterling et al. (2015) indicate that the RCADS 
may be useful in detecting depression and anxiety in youth with ASD; however, more 
convincing evidence, such as that produced by factor analysis, is needed. 
  A small body of literature has examined the invariance of self-report measures in 
individuals with ASD using factor analytic methods. Factorial invariance refers to the 
consistency of a factor model across different groups (Dimitrov, 2010). Establishing factorial 
invariance involves a hierarchy of nested levels that include tests of configural, metric (weak 
factorial invariance), scalar (strong factorial invariance), and strict factorial invariance (Meredith 
& Teresi, 2006). Configural invariance tests whether the pattern of free and fixed model 
parameters is the same across groups (Dimitrov, 2010). At the level of metric invariance, equal 
factor loadings are required across groups (Dimitrov, 2010). Scalar invariance tests whether there 
are equal item intercepts across groups (Dimitrov, 2010). Finally, strict factorial invariance 
establishes that equal item error variances and covariances exist across groups, such that group 
differences on any item are due only to differences on the common factors (Dimitrov, 2010). 
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White et al. (2015) examined the factor equivalence of anxiety as measured by the 
Multidimensional Anxiety Scale for Children (MASC; March, 1997) in youth with ASD and co-
occurring anxiety disorders and a gender-matched comparison group of typically developing 
children with anxiety disorders. The authors examined both the parent report (MASC-P) and the 
child self-report (MASC-C) versions for factor invariance. White et al. (2015) hypothesized that 
the MASC-P would demonstrate metric invariance but that the MASC-C data would not. 
Confirmatory factor analysis using structural equation modeling was conducted on the MASC-P 
and the MASC-C in the combined sample to ensure sufficient fit to test invariance. Evidence was 
found for metric invariance of the MASC-C across the two groups, suggesting that the original 
factor structure was replicable in both groups at a broad level, with the same latent factors 
emerging. However, scalar invariance was not supported across the two groups, indicating that 
the factors do not relate to each other in the same way as they do in typically developing youth. 
White et al. (2015) concluded that the MASC-C may not be an appropriate tool for assessment of 
anxiety in youth with ASD and cautioned against its use with such populations. 
Uljarevic et al. (2018) examined the psychometric properties of the Hospital Anxiety and 
Depression Scale (HADS; Zigmond & Snaith, 1983) in a sample of 151 adolescents and young 
adults with ASD. The HADS is a norm-referenced questionnaire used to assess anxiety and 
depression in community and non-psychiatric populations. Uljarevic and colleagues examined 
the HADS for latent components using principal components analysis with direct oblimin 
rotation. Two factors—interpretable as Anxiety and Depression—emerged, accounting for 43.77 
percent of variance. All items loaded in the same way as originally designed by Zigmond and 
Snaith (1983). Internal consistency was good for the HADS-Anxiety scale (alpha = .83) and 
acceptable (alpha = .65) for the HADS-Depression scale. The authors also examined convergent 
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validity by comparing the HADS to the Strengths and Difficulties Questionnaire (Goodman, 
Meltzer, & Bailey, 1998), the Warwick-Edinburgh Mental Well-being Scale (Clarke et al., 
2011), the DSM-5 Dimensional Anxiety Scales (LeBeau et al., 2012), and the Patient Health 
Questionnaire-9 (PHQ-9; Kroenke & Spitzer, 2002). There were medium to large negative 
associations between the HADS-Anxiety and HADS-Depression scales with the Warwick-
Edinburgh Mental Well-being Scale (r = -.45 and r = -.60, respectively), as well as medium to 
large positive correlations between the HADS-Anxiety and HADS-Depression scales and the 
emotional scale of the Strengths and Difficulties Questionnaire (r = .80 and r = .29. 
respectively). Additionally, there was a large positive correlation between the HADS-Anxiety 
scale and the DSM-5-Dimensional Anxiety Scale (r = .71) and a medium correlation between the 
HADS-Depression scale and the PHQ-9 (r = .56). Divergent validity of the HADS was also 
acceptable, as demonstrated by non-significant correlations with chronological age and ASD 
severity as measured by the Social Responsiveness Scale (SRS; Constantino & Gruber, 2005) 
and the abridged Autism-Spectrum Quotient (AQ-Short; Hoekstra et al., 2011). Taken together, 
the results of Uljarevic et al. (2018) suggest that the HADS provides a reliable and valid 
assessment of anxiety and depression in older adolescents and adults with ASD. 
Gotham, Unruh, and Lord (2015) examined response patterns and associations between 
scores on common measures of depressive symptoms in a sample of 50 verbally fluent 
adolescents and adults with ASD, ranging from age 16 to 31 years. Participants completed the 
BDI-II (Beck, Steer, & Brown, 1996), a self-report questionnaire that measures emotions related 
to depression, somatic symptoms, and lifestyle changes; the Self-Report Depression 
Questionnaire (SRDQ; Reynolds & Baker, 1988), a questionnaire designed to measure physical, 
cognitive, and behavioral aspects of depression in adults with mild to moderate intellectual 
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disability; and the Adult Self-Report (ASR; Achenbach & Rescorla, 2003), a measure that 
assesses a variety of symptoms, which contribute to Internalizing and Externalizing scales. 
Parents of participants completed the Children’s Depression Rating Scale (CDRS; Poznanski & 
Mokros, 1996), the CDI—Parent-Rated Version (CDI-P; Kovacs, 1992), and the Adult Behavior 
Checklist (ABCL; Achenbach & Rescorla, 2003). Scores on the various depression measures 
were not associated with chronological age or verbal IQ, which ranged from 72-140 in their 
sample. Internal consistency was acceptable to strong for the BDI-II (alpha = .97), CDI-P (alpha 
= .73), and the CDRS (alpha = .85). The authors indicated that their results provide support for 
the use of self-report measures for depression within verbally fluent individuals with ASD. 
Cassidy, Bradley, Bowen, Wigham, and Rodgers (2018) undertook a systematic review 
of the literature surrounding tools used to assess depression in adults with and without ASD. The 
authors first searched the literature for all available studies that utilized a tool to assess 
depression frequently (at least twice) with evidence of validity in adults with ASD without 
intellectual disability and adults from the general population without co-morbid conditions. Six 
tools were identified based on the above criteria and were considered further: the Hamilton 
Rating Scale for Depression (HRSD; Hamilton, 1960); Montgomery Asberg Depression Rating 
Scale (MADRS; Montgomery & Asberg, 1979); Beck Depression Inventory-Second Edition 
(BDI-II; Beck, Steer, & Brown, 1996); Center for Epidemiological Studies Depression Scale-
Revised (CESD-R; Eaton, Smith, Ybarra, Muntaner, & Tien, 2004); Patient Health 
Questionnaire (PHQ-9; Kroenke & Spitzer, 2002); and the Zung Self Rating Depression Scale 
(ZDS; Zung, 1965). In comparison to the general population, there were few studies that used 
validated tools to assess depression in adults with ASD, and none that used a tool validated 
specifically for ASD.  
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Cassidy et al. (2018) used The Consensus Based Standards for the Selection of Health 
Measurement Instruments (COSMIN; Mokkink et al., 2010a), a checklist that assesses the 
evidence for the appropriateness and measurement properties of an instrument. COSMIN rates 
the evidence in support of nine measurement properties (internal consistency; reliability; 
measurement error; content validity; structural validity; hypothesis testing; criterion validity; 
responsiveness to change; and cross-cultural validity) on a 4-point scale. The BDI-II and the 
PHQ-9 were identified as having robust evidence for a range of these properties in general 
population adults; only one study explored the psychometric properties of a validated depression 
tool (BDI-II) in adults with ASD (Gotham, Unruh, & Lord, 2015), finding it to possess strong 
internal reliability in a sample of adolescents and adults with ASD. Cassidy et al. (2018) 
highlight the need for future research studies to explore the validity of depression measures in 
adults with ASD to ensure that items relate to the relevant construct to be measured.   
Goals of the Study 
The present study seeks to determine whether the psychometric properties and factor 
structure of two self-report measures of internalizing symptoms—the Depression Anxiety Stress 
Scales-21 (DASS-21; Lovibond & Lovibond, 1995) and the Center for Epidemiologic Studies 
Depression Scale, Revised (CESD-R; Eaton et al., 2004)—are equivalent in adults with high and 
low levels of autistic traits. Previous research has indicated that the autism spectrum is a 
heterogeneous construct, with its component traits distributed across the population (Rai et al., 
2018); therefore, these traits can be measured on a continuum and used to categorize individuals 
into groups. The CESD-R is one of the most widely used instruments in the field of psychiatric 
epidemiology, particularly with regard to depression research (Eaton & Kessler, 1981; Murphy, 
2002). It possesses excellent psychometric properties within the general population (Van Dam & 
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Earleywine, 2011), but has never been investigated in the population of adults with autism. Like 
the CESD-R, the DASS measures depression, but it also examines the constructs of anxiety and 
stress, providing a broader assessment of internalizing symptoms. Nah, Brewer, Young, and 
Flower (2018) used the DASS as a screening measure for anxiety and depression in a sample of 
155 adults with autism; however, its psychometric properties were not examined in this sample 
nor in previous research. In addition, the World Health Organization (WHO) Adult ADHD Self-
Report Scale (ASRS; Kessler et al., 2005) will be examined as a measure of divergent validity. 
As the ASRS, CESD-R, and DASS are all self-report instruments, they use respondents’ own 
perceptions as the source of data. In addition, because the ASRS, CESD-R, and DASS are in the 
public domain, they can be completed quickly and do not pose a significant cost to users. 
Consequently, the current study will investigate the factorial invariance of these measures in a 
large sample of adults. 
Factorial Invariance 
 Measurement invariance refers to “whether or not, under different conditions of 
observing and studying phenomena, measurement operations yield measures of the same 
attribute” (Horn & McArdle, 1992, p. 117). Measurement invariance is a prerequisite to 
establishing factorial invariance (Ollendick & White, 2012). Relatedly, factorial invariance refers 
to whether the same construct is being measured across groups or across time. One can consider 
factorial invariance to have four levels, each of which adds additional constraints to the 
preceding level: configural invariance, metric (weak factorial) invariance, scalar (strong 
factorial) invariance, and strict factorial invariance (Meredith, 1993). Configural invariance 
refers to whether the same factor model specification holds across groups; metric invariance 
requires cross-group equality in factor loadings; scalar invariance requires cross-group equality 
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in factor loadings and intercepts; and strict factorial invariance requires cross-group equality in 
factor loadings, intercepts, and residual variances (Wu, Li, & Zumbo, 2007). In this manner, 
configural invariance assesses whether there are similar latent factors across groups, whereas 
strict factorial invariance assesses whether there is an identical item structure in both groups 
(White et al., 2015).  
Study Hypotheses 
The current study examines the factorial invariance of the ASRS (Kessler et al., 2005), 
CESD-R (Eaton et al., 2004) and DASS-21 (Lovibond & Lovibond, 1995) across two groups of 
adults: those with a) high levels and b) low levels of autistic traits, as measured by the Autism 
Spectrum Quotient (AQ; Baron-Cohen, Wheelwright, Skinner, Martin, & Clubley, 2001), a well 
validated self-report instrument which quantifies autistic traits in adults. It is hypothesized that 
neither the CESD-R nor the DASS-21 will demonstrate metric invariance across groups. Metric 
invariance suggests that the same latent constructs are being measured across groups, with any 
differences in covariances of observed items able to be attributed to latent factors (White et al., 
2015). The hypothesis that metric invariance will not hold for the DASS-21 and the CESD-R 
follows from the idea that traditional measures of anxiety and depression may not capture the 
presentation of these constructs in individuals with ASD, whether this is due to diagnostic 
overshadowing, difficulty interpreting and reporting emotions, or another pathway (Cassidy et 
al., 2018; Mazzone, Ruta, & Reale, 2012).  
In the group of adults with high levels of autistic traits, it is hypothesized that data from 
the CESD-R and the DASS-21 will not possess the same factor model specifications as 
established in general (Eaton, Smith, Ybarra, Muntaner, & Tien, 2004; Lovibond & Lovibond, 
1995; Van Dam & Earleywine, 2011) and clinical (Antony, Bieling, Cox, Enns, & Swinson, 
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1998; Brown, Chorpita, Korotitsch, & Barlow, 1997) adult populations. In addition, it is 
hypothesized that convergent validity will be demonstrated between the CESD-R and the 
Depression scale of the DASS-21, as evidenced by significant correlation coefficients.  
Third, it is hypothesized that ADHD symptoms as measured by the ASRS will be 
divergent from depression and anxiety symptoms, as measured by the CESD-R and the DASS-
21, given the different constructs assessed within the ASRS (i.e., inattention and hyperactivity-
impulsivity) as opposed to the other two self-report measures. 
Finally, it is hypothesized that anxiety will be divergent from depression both within and 
between self-report measures among the group of adults with low levels of autistic traits, but not 
within the group of adults with high autistic traits, given the potential for greater diagnostic 
overshadowing within ASD populations. 
Method 
Participants 
Approval from the Institutional Review Board of Syracuse University was attained before 
commencement of the study. Electronic informed consent was obtained from all study 
participants. Participants were required to enter the date on which they completed the survey to 
formalize their agreement to participate in the study. This was a convenience sample of 
participants who responded to a survey posted on Amazon Mechanical Turk, an online labor 
market. All participants were recruited through Human Intelligence Tasks (“HITs”) posted on 
Amazon Mechanical Turk titled “Answer a survey about your mood, emotions, and behavior.” 
The description of the survey was listed as “Answer questions designed to understand how 
people think, feel, and behave in everyday life.” Accompanying keywords were “survey,” 
“research,” and “psychology.”  
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Participants were adults located within the United States who were of at least 18 years of 
age. Individuals located outside the United States were restricted from participation given that 
study measures were normed using data collected within the United States, and all study 
materials were in English. Additionally, the constructs of depression and anxiety might differ 
cross-culturally, in a way that may not be captured adequately by the CESD-R and the DASS-21 
(Byrne & Campbell, 1999; Byrne & van de Vijver, 2010; Chen, 2008). In addition to completion 
of the psychological measures, participants completed questions about demographic information 
including age, gender, and race/ethnicity.  
Measures 
World Health Organization Adult ADHD Self-Report Scale 
The World Health Organization (WHO) Adult ADHD Self-Report Scale (ASRS; Kessler 
et al., 2005) is a self-report screening scale of adult attention-deficit/hyperactivity disorder that 
was developed in conjunction with the revision of the WHO Composite International Diagnostic 
Interview. The ASRS consists of 18 questions regarding the frequency of Diagnostic and 
Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV-TR; American Psychiatric 
Association, 2000) symptoms of ADHD. Respondents are asked to use a 5-item Likert scale to 
indicate the frequency of occurrence of symptoms over the last six months, with answer 
categories of “never,” “rarely,” “sometimes,” “often,” and “very often.” The ASRS consists of 
two subscales, Inattention and Hyperactivity-Impulsivity, each consisting of 9 items. The total 
sum of the ASRS ranges from 0 to 72.  
The ASRS has demonstrated good reliability and validity in both clinical and population 
samples (Adler et al., 2006; Silverstein et al., 2018; van de Glind et al., 2013; Vildalen et al., 
2016). In previous studies, the ASRS has been shown to have moderate sensitivity, high 
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specificity, and high total classification accuracy, with values of .56, .98, and .96, respectively 
(Kessler et al., 2005).  
In the normative sample, the ASRS possessed good internal consistency, with a 
Cronbach’s alpha value of 0.88 in a sample of 60 adults evaluated for ADHD. In an independent 
analysis, Vildalen et al. (2019) reported Cronbach’s alpha values of .93 for inattention and .91 
for hyperactivity/impulsivity, with almost identical values for females (.93 and .91) and males 
(.92 and .91), in a sample of 1,564 adult participants. In addition, ASRS scores have been shown 
to be stable cross-culturally with Hungarian (Farcas et al., 2018), Israeli (Zohar & Konfortes, 
2010), Korean (Kim, Lee, & Joung, 2013), and Taiwanese (Yeh et al., 2008) samples.  
Autism-Spectrum Quotient 
The Autism-Spectrum Quotient (AQ; Baron-Cohen, Wheelwright, Skinner, Martin, & 
Clubley, 2001) is a self-administered questionnaire that assesses the degree to which an 
individual without intellectual disability possesses traits associated with the autism spectrum. 
The AQ consists of 50 items assessing personal preferences and habits, divided into five 
subscales of 10 items each: social skill; communication; imagination; attention to detail; and 
attention switching. Individuals are asked to rate to what extent they agree or disagree with the 
statements (e.g., “I notice patterns in things all the time”; “I find social situations easy”) on a 4-
point Likert scale, with answer categories of “definitely agree,” “slightly agree,” “slightly 
disagree,” and “definitely disagree.” Approximately half of items are worded to produce an 
‘agree’ response, and half a ‘disagree’ response, in order to avoid response bias. Each item is 
scored one point if the respondent endorses the behavior associated with ASD (i.e., poor social 
skill, poor communication skill, poor imagination, exceptional attention to detail, poor attention-
switching/strong focus of attention).  
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The AQ has demonstrated utility in distinguishing individuals who have clinically 
significant levels of autistic traits, and AQ sum scores are normally distributed in the general 
population (Hurst, Mitchell, Kimbrel, Kwapil, & Nelson-Gray, 2007). An AQ total score of 32 is 
the recommended cutoff for use in the general population, as 79.3 percent of a group of adults 
with Asperger syndrome or high-functioning autism scored at this level compared to 2 percent of 
controls (Baron-Cohen et al., 2001). Although not a diagnostic instrument, the AQ has 
demonstrated diagnostic validity, with good discriminative validity and screening properties 
using a threshold score of 26 (Woodbury-Smith, Robinson, Wheelwright, & Baron-Cohen, 
2005).  
With regard to internal consistency, Cronbach’s alpha coefficients were moderate to 
acceptable for all domains (Communication = .65; Social skill = .77; Imagination = .65; 
Attention to detail = .63; Attention switching =.67). In an independent analysis, Austin (2005) 
reported similar findings (Communication = .61; Social skill = .75; Imagination = .65; Attention 
to detail = .66; Attention switching = .58), as well as a coefficient alpha of .82 for the total AQ 
score. Test-retest coefficients were r = .7 in a sample of 17 university students who completed a 
second AQ two weeks after a first administration (Baron-Cohen et al., 2001). In addition, AQ 
scores have been shown to be stable cross-culturally with Japanese (Kurita, Koyama, & Osada, 
2005; Wakabayashi, Baron-Cohen, Wheelwright, & Tojo, 2006) and Dutch samples (Hoekstra, 
Bartels, Cath, & Boomsma, 2008).  
Center for Epidemiologic Studies Depression Scale-Revised 
The Center for Epidemiologic Studies Depression Scale-Revised (CESD-R; Eaton, 
Smith, Ybarra, Muntaner, & Tien, 2004) is a self-report scale used to assess symptoms of 
depression in the general population. The CESD-R is an updated version of the Center for 
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Epidemiologic Studies Depression Scale (CES-D; Radloff, 1977), which was originally 
composed of four factors: depressed affect, absence of positive affect, somatic activity/inactivity, 
and interpersonal difficulties. The CES-D was revised to reflect the primary symptoms of a 
major depressive episode according to criteria from the Diagnostic and Statistical Manual of 
Mental Disorders, Fourth Edition (DSM-IV-TR; American Psychiatric Association, 2000). In 
comparison to the CES-D, the CESD-R includes an extra response category (nearly every day for 
two weeks), as well as additional items reflecting anhedonia, psychomotor retardation/agitation, 
and suicidal ideation. The CESD-R consists of 20 items, which correspond to the nine cardinal 
symptoms of major depressive disorder as conceptualized by the DSM: sadness (dysphoria); loss 
of interest (anhedonia); appetite; sleep; thinking/concentration; guilt (worthlessness); tired 
(fatigue); movement (agitation); and suicidal ideation. Respondents are asked to select how often 
they have felt this way during the past week, with five response options: “not at all or less than 1 
day”; “1-2 days”; “3-4 days”; “5-7 days”; or “nearly every day for 2 weeks.” The total CESD-R 
score is calculated as the sum of responses to all 20 questions. Total CESD-R scores range 
between zero (for those who respond “not at all or less than 1 day” to all questions) and 60 (for 
those who respond “5-7 days” or “nearly every day for 2 weeks” to all questions). Scores greater 
than or equal to 16 indicate that the respondent is at risk for clinical depression (Radloff, 1977).  
 The CESD-R has been validated in several samples (Eaton et al., 2004; Van Dam & 
Earleywine, 2011). The CESD-R possessed excellent internal consistency across these studies, 
with alpha ranging from .90 to .93. Item-total correlations ranged from .32 to .75 in a sample of 
nurse assistants (Eaton et al., 2004). The overall correlation between the original CESD and the 
CESD-R in this sample was .88, which suggests that the two scales are measuring the same 
construct. The CESD-R also demonstrated theoretically consistent convergent and divergent 
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validity with anxiety, schizotypy, and positive and negative affect (Van Dam & Earleywine, 
2011). Van Dam and Earleywine (2011) performed both exploratory and confirmatory factor 
analyses, finding that a two-factor model fit the data significantly better than a one-factor 
solution in two samples; however, the inter-factor correlation was .941 in sample 1 and .975 in 
sample 2, suggesting factor redundancy. 
Depression Anxiety Stress Scales 
The Depression Anxiety Stress Scales (DASS; Lovibond & Lovibond, 1995) are a set of 
self-report scales designed to measure the magnitude of three negative emotional states: 
depression, anxiety, and stress. Two versions, one with 42 items and one with 21 items, of the 
DASS are offered, with the DASS-21 (Lovibond & Lovibond, 1995) consisting of a subset of 
items from the DASS. Each of the three scales consists of either 14 or 7 items, divided into 
subscales of similar content. The Depression scale assesses dysphoria, hopelessness, devaluation 
of life, lack of interest/involvement, anhedonia, inertia, and self-deprecation. The Anxiety scale 
assesses autonomic arousal, skeletal musculature effects, situational anxiety, and the subjective 
experience of anxious affect. The Stress scale assesses difficulty relaxing, nervous arousal, being 
easily agitated, easily irritable, or impatient. The individual is asked to use a 4-point scale to rate 
the extent to which they have experienced each symptom over the past week. 
 Internal consistencies for each scale for the DASS normative sample were good to 
excellent, with a coefficient alpha of .91 for Depression, .84 for Anxiety, and .90 for Stress 
(Lovibond & Lovibond, 1993). Norton (2007) assessed the psychometric properties of the 
DASS-21 among different racial groups, finding it to possess adequate internal consistency 
(coefficient alphas ranging from .78 to .87) across groups. Similarly, the DASS-21 has evidence 
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of good convergent and discriminant validity when compared to other measures of depression 
and anxiety (Henry & Crawford, 2005). 
 The DASS has also been examined in outpatient samples of individuals presenting for 
assessment and treatment of anxiety and mood disorders. Test-retest reliability was assessed in a 
group of 20 patients who were re-administered the DASS two weeks after their initial evaluation. 
All three scales of the DASS evidenced temporal stability, with test-retest coefficients of .713, 
.785, and .813 for Depression, Anxiety, and Stress, respectively (Brown, Chorpita, Korotitsch, & 
Barlow, 1997). In addition, exploratory factor analysis with principal components extraction 
suggested a three-factor solution (Antony, Bieling, Cox, Enns, & Swinson, 1998), in fitting with 
Lovibond and Lovibond (1995). Studies that have directly compared the full DASS and the 
DASS-21 in clinical populations suggest that the DASS-21 is associated with a cleaner factor 
structure relative to the DASS-42 (Antony et al., 1998; Clara, Cox, & Enns, 2001). Taken 
together, these results provide support for the validity of the DASS in clinical populations. 
Procedure 
 Participants used Amazon’s Mechanical Turk (MTurk; http://www.mturk.com/) to 
complete the survey. MTurk is an online labor market created by Amazon designed to assist 
“requesters” in hiring and paying “workers” for the completion of computer-based tasks, referred 
to as “Human Intelligence Tasks” or “HITs.” Workers are paid by requesters upon successful 
completion of HITs (Paolacci & Chandler, 2014). All MTurk workers are required to sign a 
participation agreement electronically confirming that they are at least 18 years of age in order to 
use the platform. Research has generally indicated that MTurk workers provide high-quality 
data, as evidenced by equivalence to other data collection methods with regard to internal 
consistency and test-retest reliability (Shapiro, Chandler, & Mueller, 2013). 
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 After accepting the HIT on MTurk, participants were redirected to a Qualtrics survey, in 
which they completed demographic information questions, the ASRS, the AQ, the CESD-R, and 
the DASS-21. Within the Qualtrics survey, each of the aforementioned survey elements was 
randomly presented using block randomization, with each element presented roughly an equal 
number of times across all respondents. To protect participants’ anonymity, all survey responses 
were collected through Qualtrics. Specifically, Amazon has access to workers’ personal 
identifiable information and survey responses (Mason & Suri, 2011) and automatically collects 
Internet Protocol (IP) addresses for all participants, increasing the risk that data may be 
identifiable. Upon completion of the survey, participants received a completion code, identical 
for all participants, which was used for the purposes of compensation on the MTurk platform. 
 Participants were compensated $1.50 for completing the full survey consisting of 
demographic questions, the ASRS, the AQ, the CESD-R, and the DASS-21. In order to achieve 
an optimal number of participants across both the low ASD traits and high ASD traits groups, all 
participants were screened using the AQ. Upon reaching 230 participants in the low ASD traits 
group, survey respondents with an AQ score less than 26 were routed to the end of the survey, 
and survey respondents with an AQ score greater than or equal to 26 were routed to complete all 
study measures. Participants who were routed to complete only the AQ were paid $0.30, whereas 
those who were routed to complete all study measures were paid $1.50.  
 Data for the present study were collected from April 2019 to October 2019 on MTurk. 
During this period, 17 HITs were posted to MTurk consisting of 20 (5.9% of total HITs), 50 
(76.5% of total HITs), or 100 assignments (17.6% of total HITs) per HIT. Each HIT reached its 
total number of assignments in a minimum of 2 days and a maximum of 7 days. In total, 997 
responses were collected. Of those 997 responses, 434 (43.5%) were included in the final 
28 
 
sample. The 563 responses that were not included in the final sample comprised participants who 
completed the AQ and then were routed to the end of the survey or who failed four out of four 
attention checks (n = 3). 
Power Analysis 
 The power of a test is its “sensitivity or ability to detect what is present” (Maxwell & 
Delaney, 2004, p. 24). In other words, power is the probability of rejecting the null hypothesis 
when it is false. A power analysis can provide further information regarding the likelihood that a 
given experimental design will detect an effect of a particular size in a population (Maxwell & 
Delaney, 2004). In this manner, one can use a power analysis to determine the sample size 
necessary to provide an experiment with adequate power.  
 The minimum sample size required to achieve a power of .80 was calculated using the 
statistical program R (R Core Team, 2018), with syntax generated from Preacher and Coffman 
(2006). The program generated the minimum sample size needed to use the Root Mean Square 
Error of Approximation (RMSEA; Steiger & Lind, 1980) to assess goodness of model fit within 
structural equation modeling (MacCallum, Browne, & Sugawara, 1996). Alpha was set at .05, 
with 190 degrees of freedom, corresponding to the number of potentially estimable parameters of 
interest when conducting structural equation modeling on the CESD-R. A null RMSEA value of 
.05 was specified as achieving adequate model fit, with an alternative RMSEA value of .08 
signifying a poor model fit. In this sense, effect size in this approach is defined in terms of the 
difference in overall fit of the two models, as indexed by the specified RMSEA values 
(MacCallum, Browne, & Cai, 2006). The above analysis yielded a minimum of 87 participants 
per group in order to achieve a power of .80. 
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 Importantly, however, the power analysis above does not take both groups (high and low 
levels of autistic traits) into account, as it is unknown how many individuals with high autistic 
traits exist in the population. Therefore, 87 participants per group can be considered a minimum 
estimate of the number of participants needed for the proposed study. Sample size has a 
considerable impact on both reliability and validity in the context of factor analysis (Kyriazos, 
2018). Several guidelines have been suggested with regard to achieving adequate sample size for 
use in a confirmatory factor analysis, including an N greater than 200 (Comrey, 1988); a ratio of 
10 participants per indicator variable (Wang & Wang, 2012); or a ratio of 20 participants for 
every parameter estimated (Jackson, 2003). Given that large samples are crucial for models with 
accurate parameter estimates, particularly when normality assumptions are not met (MacCallum 
et al., 1996), the present study adopted a more conservative sample size. Consequently, the 
present study used quota sampling in an attempt to include a minimum sample size of 210 
participants in each group (high and low levels of autistic traits) to align with the 21-item version 
of the DASS, in fitting with the ratio of 10 participants for every indicator variable (Wang & 
Wang, 2012). Consequently, participant data was split into two groups: those who have a high 
level of autistic traits (total AQ score greater than or equal to 26) and those who have a low level 
of autistic traits (total AQ score less than 26). This cut-off is in accordance with previous 
research by Woodbury-Smith et al. (2005) as mentioned above, which indicated that the AQ 
correctly identified 83 percent of patients in a referred clinical sample using a cut-off score of 26. 
Data Analysis Strategy 
 Confirmatory factor analysis, using structural equation modeling in Mplus Version 8.4 
(Muthen & Muthen, 2017), employing the standard CESD-R, DASS, and ASRS factor structure 
was conducted in the combined sample for each measure to ensure sufficient fit to test 
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invariance. The same confirmatory factor analysis was then run on the low ASD traits and high 
ASD traits groups in multigroup invariance analyses. In all invariance models, the low ASD traits 
group served as the reference group and the high ASD traits group served as the alternative 
group.  
 Analyses began with the test of configural invariance, in which latent factor means were 
constrained to be 0 and factor variance was fixed to 1 for identification within each group. All 
other parameters were freely estimated. This tested whether the same pattern or factor structure 
existed in both groups. 
 Next, the test for metric (weak factorial) invariance was conducted by constraining 
loadings of observed items onto latent factors to be equal across both groups. Specifically, factor 
variance was fixed to 1 in the low ASD traits group but was freely estimated in the high ASD 
traits group, and factor means were fixed to 0 in both groups. Intercepts and residual variances 
were permitted to vary across groups. 
 In addition to the constraints imposed by the test of metric invariance, the test of scalar 
(strong factorial) invariance specified item intercepts to be equal across groups. Specifically, 
factor means and variances were fixed to 0 and 1, respectively, for identification within the low 
ASD traits group; factor means and variances were then estimated in the high ASD traits group. 
Factor loadings and item intercepts were constrained to be equal across groups. Residual 
variances were permitted to differ across groups. 
 Finally, the test of strict invariance constrained residual variances to be equal across 
groups, in addition to the constraints imposed in the previous models. In particular, factor means 
and variances were fixed to 0 and 1, respectively, for identification in the low ASD traits group; 
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factor means and variances were estimated in the high ASD traits group. All factor loadings, item 
intercepts, and residual variances were constrained to be equal across groups. 
Results 
Descriptive Statistics 
 Descriptive statistics were analyzed using JASP Version 0.9.01 (JASP Team, 2019), R (R 
Core Team, 2017), and IBM SPSS Statistics for Windows Version 25.0 (IBM, 2017). The low 
ASD traits group was compared to the high ASD traits group to assess differences on basic 
demographic factors using univariate ANOVAs for continuous variables and χ2 tests for 
categorical variables. Descriptive statistics for study variables and demographic factors are 
presented in Table 1. There were no significant differences between groups with regard to age, 
gender, native language, and race/ethnicity. Total scores on all study measures, including the 
ASRS, AQ, CESD-R, and DASS, were significantly higher in the high ASD traits group.  
Missing Data 
 Missing values were examined to determine patterns of missingness and the necessity of 
subsequent analytical adjustments. Missing data analyses revealed a maximum level of 
missingness at 2.99% (23 items), with all other items at < 2.8% missingness (M missing = 1.6%; SD 
missing = 1.2%) and a minimum level of missingness of 0.23% (5 items). Little’s test indicated that 
data were not missing completely at random [MCAR], χ2 (277) = 590.5, p < .001. Consequently, 
the missingness pattern was explicitly examined in order to diagnose the missing data 
mechanism. Investigation of the missingness pattern suggested that for items with the greatest 
percent missing data (i.e., ≥ 2.5%), the pattern could be attributable to sample differences given 
that data were missing by design. Specifically, in order to achieve an optimal number of 
participants across both the low ASD traits and high ASD traits groups, all participants were 
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screened using the AQ. Upon reaching 230 participants in the low ASD traits group, survey 
respondents with an AQ score less than 26 were routed to the end of the survey, and survey 
respondents with an AQ score greater than or equal to 26 were routed to complete all study 
measures. Consequently, because the data that were missing by design could be said to be 
missing at random [MAR], no model adjustments were made in subsequent factorial invariance 
analyses. 
Bivariate Correlations Within Study Measures 
 Correlation coefficients were calculated for all three self-report measures across both the 
low ASD traits and high ASD traits groups as a measure of shared variance. Bivariate 
correlations among study variables are presented in Tables 2-7. Importantly, most of the items of 
the DASS-21 and all the items of the CESD-R demonstrated high skewness and kurtosis, 
indicating a non-normal distribution for these data. Skewness and kurtosis values for all study 
measures in the combined sample are presented in Table 8.  
Inter-Item Correlations 
 Average inter-item correlation was calculated for each of the three measures as an 
indicator of item redundancy. The overall CESD-R total score demonstrated medium to large 
inter-item correlations in the low ASD traits (MIIC = .52) and high ASD traits (MIIC = .46) groups. 
For the ASRS, inter-item correlations were medium to large for both the low ASD traits 
(Inattention MIIC = .55; Hyperactivity-Impulsivity MIIC =.43) and high ASD traits (Inattention 
MIIC = .42; Hyperactivity-Impulsivity MIIC =.33) groups. Similarly, for the DASS-21, inter-item 
correlations were large in both the low ASD traits (Depression MIIC = .69; Anxiety MIIC =.57; 




Bivariate Correlations Between Study Measures 
 All correlations between total scores and subscale scores for all measures were 
significant. Bivariate correlations between subscale scores for the low ASD traits and high ASD 
traits groups are presented in Table 9. Correlations between raw total scores for the CESD-R and 
each of the DASS-21 subscales were strong for the overall sample (DASSDepression: r = .86; 
DASSAnxiety: r = .73; DASSStress = .81). Correlations between raw total scores for the CESD-R 
and the two subdomains of the ASRS were moderate to strong for the overall sample 
(ASRSInattention: r = .59; ASRSHyperactivity-Impulsivity: r = .63). Correlations between raw total scores 
for the ASRS and each of the DASS-21 subscales were moderate to strong for the overall sample 
(ASRSInattention-DASSDepression: r = .60; ASRSInattention-DASSAnxiety = .51; ASRSInattention-DASSStress 
= .61; ASRSHyperactivity-Impulsivity DASSDepression: r = .60; ASRSHyperactivity-Impulsivity-DASSAnxiety: 
r=.65; ASRSHyperactivity-Impulsivity-DASSStress: r = .69). 
Internal Consistency 
 As a measure of internal consistency, Cronbach’s alpha (Cronbach, 1951) was calculated 
for each factor and the overall scale for each of the study measures using the formula α = (N*𝑐̅) / 
?̅? + (N – 1) * 𝑐̅, where N is equal to the number of items, 𝑐̅ is the average inter-item covariance 
among item pairs, and ?̅? is the average variance. Cronbach’s alpha estimates for each scale are 
presented in Table 10. 
Model Estimation 
 Because study variables could not be assumed to be normally distributed, full information 
maximum likelihood estimation with robust standard errors was used. In addition, maximum 
likelihood estimation is an optimal method for the treatment of missing data in a confirmatory 
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factor analysis, as it is robust to missing completely at random and missing at random data 
(Arbuckle, 1996).  
Baseline Models 
CESD-R 
 The baseline model demonstrated acceptable fit in the combined sample (χ2 [170] = 
591.124, p < .001; RMSEA = .076 [90% CI: .07 - .083]; CFI = .853; TLI = .836; SRMR = .06), 
thus providing sufficient evidence to proceed with multigroup factorial invariance testing.  
DASS-21 
 The baseline model demonstrated good fit in the combined sample (χ2 [266] = 591.57, p 
< .001; RMSEA = .054 [90% CI: .048 - .060]; CFI = .918; TLI = .910; SRMR = .043), thus 
providing sufficient evidence to conduct multigroup factorial invariance testing. 
ASRS 
 The baseline model demonstrated acceptable fit in the combined sample (χ2 [201] = 
559.67, p < .001; RMSEA = .065 [90% CI: .059 - .072]; CFI = .868; TLI = .852; SRMR = .054), 
thus providing sufficient evidence to conduct multigroup factorial invariance testing. 
Multifactorial Invariance Analyses 
CESD-R 
 Unstandardized parameter estimates for the test of configural invariance across the low 
ASD traits and high ASD traits groups are presented in Figure 1a. Model fit indices for the test of 
configural invariance are presented in Table 11.  
 Metric invariance. Unstandardized parameter estimates for the test of metric invariance 
of the CESD-R across both the low ASD traits and high ASD traits groups are presented in 




 Unstandardized parameter estimates for the test of configural invariance across the low 
ASD traits and high ASD traits groups are presented in Figure 2a. Model fit indices for the test of 
configural invariance are presented in Table 11.  
 Metric invariance. Unstandardized parameter estimates for the test of metric invariance 
of the DASS-21 across the low ASD traits and high ASD traits groups are presented in Figure 2b. 
Model fit indices for the test of metric invariance are presented in Table 11.  
 Scalar invariance. Unstandardized parameter estimates for the test of scalar invariance 
of the DASS-21 across the low ASD traits and high ASD traits groups are presented in Figure 2c. 
Model fit indices for the test of scalar invariance are presented in Table 11.  
 Strict invariance. Unstandardized parameter estimates for the test of strict invariance of 
the DASS-21 across the low ASD traits and high ASD traits groups are presented in Figure 2d. 
Model fit indices for the test of strict invariance of the DASS-21 are presented in Table 11. 
ASRS 
 Unstandardized parameter estimates for the test of configural invariance across the low 
ASD traits and high ASD traits groups are presented in Figure 3a. Model fit indices for the test of 
configural invariance for the ASRS are presented in Table 11.  
 Metric invariance. Unstandardized parameter estimates for the test of metric invariance 
of the ASRS across both the low ASD traits and high ASD traits groups are presented in Figure 
3b. Model fit indices for the test of metric invariance are presented in Table 11.  
 Scalar invariance. Unstandardized parameter estimates for the test of scalar invariance 
of the ASRS across the low ASD traits and high ASD traits groups are presented in Figure 3c. 
Model fit indices for the test of scalar invariance for the ASRS are presented in Table 11. 
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 Strict invariance. Unstandardized parameter estimates for the test of strict invariance of 
the ASRS across the low ASD traits and high ASD traits groups are presented in Figure 3d. 
Model fit indices for the test of strict invariance of the ASRS are presented in Table 11. 
Model Comparisons 
 Because all models were nested, all model comparisons were conducted via the 
difference in each model’s chi-square value. The Satorra-Bentler scaled chi-square difference 
test was used to examine differences in fit between models, given that maximum likelihood 
estimation with robust standard errors was used in each model. Additionally, the sample size-
adjusted Bayesian Information Criterion (BIC) was used, with a 10-point difference taken as 
evidence of a model difference in goodness of fit in favor of the model with the smaller BIC 
(Raftery, 1993).  
CESD-R 
 In general, both the configural and metric models possessed poor fit to the data, with all 
model fit indices outside of the acceptable range (see Table 11). Consequently, multifactorial 
invariance testing was discontinued and post-hoc exploratory factor analysis was conducted. In 
order to determine if data were suitable for factor analysis, the Kaiser-Meyer-Olkin (KMO) 
measure of sampling adequacy and Bartlett’s test of sphericity were assessed, with an overall 
KMO of .8 or above considered excellent, and an overall KMO of less than .5 considered poor 
(Tabachnick & Fidell, 2007). KMO for the CESD-R data was .943. Similarly, Bartlett’s test of 
sphericity was significant, indicating that factor analysis on the CESD-R data would be suitable. 
 An exploratory factor analysis using maximum likelihood with robust standard errors 
(MLR) with an oblique (geomin) rotation was used. A three-factor solution fit the data best, with 
37 
 
three eigenvalues > 1 and RMSEA = 0.06 (90% CI: .054 - .069). Items within each of the three 
identified factors are presented in Table 12.  
DASS-21 
 Overall, the metric invariance model fit well, except for the standardized root mean 
square residual (SRMR) index (see Table 11). The metric model did not exhibit a statistically 
significant reduction in fit relative to the configural model, χ2(15) = 10.52, p = .785. This was 
also supported when examining change in the sample size-adjusted BIC, as ΔBIC = 28.87 when 
moving from the metric model to the configural model. The scalar invariance model also fit well 
(see Table 11), and there was not a significant decrease in fit in relation to the metric invariance 
model, χ2(18) = 18.09, p = .449. Similarly, when examining the scalar model in relation to the 
metric model, ΔBIC = 32.34. Finally, the strict invariance model demonstrated acceptable fit 
(see Table 11); however, the strict invariance model exhibited a significant decrease in fit 
relative to the scalar model, χ2(21) = 157.32, p < .001, indicating that scalar invariance was 
supported in the present sample.  
ASRS 
 The metric invariance model possessed moderate to poor fit to the data (see Table 11). 
The metric model did not demonstrate a statistically significant reduction in fit relative to the 
configural model, χ2(14) = 10.77, p = .704. When examining change in sample-size adjusted 
BIC, there was a difference of 28.95 when moving from the metric model to the configural 
model. Model fit indices continued to be poorly fit to the data (see Table 11). When examining 
the scalar model, there was a statistically significant reduction in fit relative to the metric model, 
χ2(16) = 31.11, p =.013, indicating that scalar invariance of the measure was not supported in the 
present sample. Finally, model fit indices were poor across all indicators for the test of strict 
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factorial invariance (see Table 11). Consequently, the ASRS demonstrated metric invariance in 
the current sample. 
Discussion 
 Individuals with ASD present with high rates of anxiety and depression, with rates that 
are greater than that seen in the general population (Croen et al., 2015; Joshi et al., 2013; 
Wigham, Barton, Parr, & Rodgers, 2017). At the same time, the reliability and validity of many 
traditional measures of these and other mental health conditions have not been tested in the ASD 
population (Leyfer et al., 2006). Consequently, it is essential to assess whether common self-
report measures of anxiety and depression can adequately assess these constructs in individuals 
with and without ASD. To this aim, the present study included factorial invariance analyses of 
three self-report measures of psychiatric symptoms—the ASRS, the CESD-R, and the DASS-
21—among adults with low and high levels of ASD-related traits.  
 In comparison to the low ASD traits group, participants in the high ASD traits group 
scored significantly higher on all study measures. Specifically, subscale scores and total scale 
scores on the ASRS, the CESD-R, and the DASS-21 were significantly higher in the high ASD 
traits group, indicating greater self-reported symptoms of depression, anxiety, stress, inattention, 
and hyperactivity in those with a higher level of ASD-related traits.  
 Importantly, none of the self-report measures examined in the present study demonstrated 
full factorial invariance, indicating that the measures are not consistent in their performance 
across individuals with a high and low level of ASD-related traits.  
Hypothesis 1 
 It was hypothesized that neither the CESD-R nor the DASS-21 would demonstrate metric 
invariance across groups, given that traditional measures of anxiety and depression may not 
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capture the presentation of these constructs in individuals with ASD, whether due to diagnostic 
overshadowing, difficulty interpreting and reporting emotions, or another pathway (Cassidy et 
al., 2018; Mazzone, Ruta, & Reale, 2012).  
CESD-R 
 The original hypothesis that the CESD-R would not demonstrate metric invariance across 
groups was supported in the current study. Indeed, the CESD-R did not demonstrate evidence of 
acceptable model fit within the test of configural invariance, indicating that the same factor 
model specification did not hold across both the low ASD traits and high ASD traits groups. 
Instead, results of an exploratory factor analysis indicated that a three-factor solution fit the data 
best. 
 In examining the items that loaded onto the three identified factors, several themes 
appeared. One factor seemed to be concerned with negative affect (e.g., items included: “I could 
not shake off the blues”; “I felt depressed”; “I felt sad”; “I did not like myself”; etc.). Another 
factor involved physical symptoms associated with depression (e.g., items included: “My 
appetite was poor”; “My sleep was restless”; “I felt like I was moving too slowly”; “I felt 
fidgety”; etc.). Finally, the third factor comprised only two items, both of which could be related 
to behavioral components of depression: “I wanted to hurt myself” and “I lost a lot of weight 
without trying to.” The results of the exploratory factor analysis stand in contrast to previous 
research from the initial validation of the measure which found that a one-factor solution 
provided the best fit. Although results of the present study indicate that more than a single factor 
provides the best fit to the data, it is possible that the overarching construct of depression is 
common to all three identified factors and thus remains the most parsimonious factor model for 




 The original hypothesis that the DASS-21 would not demonstrate metric invariance 
across groups was not supported in the present study. In contrast, there was evidence for scalar 
invariance of the DASS-21, indicating equality in intercepts, factor loadings, and an identical 
factor model specification across groups. Importantly, however, there was significant 
degradation in model fit when examining strict invariance of the DASS-21, indicating that there 
are not equal residual variances across the low ASD traits and high ASD traits groups. 
Subsequently, the DASS-21 does not possess an identical item structure in those with a high and 
low level of ASD-related traits; however, attaining scalar invariance justifies the comparisons of 
group means on the latent constructs that the DASS-21 purports to measure (i.e., depression; 
anxiety; stress). In this sense, group differences on items of the DASS-21 are not solely due to 
differences on the common factors but are a result of some degree of measurement error. Given 
that scalar invariance of the DASS-21 was supported in the current sample, one can have 
confidence that the DASS-21 is able to measure symptoms of depression, anxiety, and stress 
fairly consistently across individuals with a high and low level of ASD-related traits. 
ASRS 
 The ASRS was also examined in the present study in order to obtain further information 
about discriminant validity, as well as whether factorial invariance would be demonstrated 
within measures that did not specifically measure internalizing symptoms. The ASRS 
demonstrated metric invariance in the current sample, indicating equality in factor loadings in 
addition to an identical factor model specification across groups. Importantly, however, there 
was a significant decrease in model fit when examining scalar invariance of the ASRS, 
indicating that there are not equal item intercepts across the low ASD traits and high ASD traits 
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groups. Although the ASRS is measuring similar latent factors in both groups, it is not 
performing equally across both groups at the level of individual items. Thus, the constructs being 
measured by the ASRS (i.e., inattention; hyperactivity/impulsivity) have similar meanings to 
individuals with varying levels of ASD-related traits, but the levels and relations among the 
factors of the ASRS differ meaningfully in those with varying levels of ASD-related traits. 
Because metric invariance was supported in the present sample, one can justify comparisons of 
factor variances and covariances across those with a high and low level of ASD-related traits, but 
one cannot assume that the ASRS functions equally in individuals with different levels of ASD-
related traits. 
Hypothesis 2 
 Additionally, it was hypothesized that data from the CESD-R and the DASS-21 would 
not possess the same factor model specifications in the high ASD traits group as were established 
in general (Eaton, Smith, Ybarra, Muntaner, & Tien, 2004; Lovibond & Lovibond, 1995; Van 
Dam & Earleywine, 2011) and clinical (Antony, Bieling, Cox, Enns, & Swinson, 1998; Brown, 
Chorpita, Korotitsch, & Barlow, 1997) adult populations. 
CESD-R 
 The hypothesis that the CESD-R would not possess the same factor model specifications 
as established in general and clinical adult populations was supported in the present study. In 
comparison to the standardized factor loadings from a confirmatory factor analysis conducted by 
Van Dam and Earleywine (2011) of a community sample of 3650 adults, standardized factor 
loadings of the CESD-R items for the high ASD traits group demonstrated a discrepancy of 
greater than .30 for 9 out of 20 CESD-R items. For instance, items such as “I lost a lot of weight 
without trying to” and “I felt fidgety” demonstrated respective factor loadings of .36 and .48 in 
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the high ASD traits group of the current sample versus .61 and .76 in the work of Van Dam and 
Earleywine (2011). In comparison, the same items possessed standardized factor loadings of .54 
and .76 in the low ASD traits group of the current sample, in alignment with findings of Van 
Dam and Earleywine (2011). Items that seemed most strongly associated with the construct of 
depression in the community sample of Van Dam and Earleywine (2011) did not demonstrate 
comparable factor loadings within the high ASD traits group of the current study. Specifically, 
standardized factor loadings of items including “I felt sad”, “I could not get going”, “Nothing 
made me happy”, “I felt like a bad person”, and “I lost interest in my usual activities” were all 
within the range of .72-.83. In contrast, standardized factor loadings of the same items in the 
community sample of Van Dam and Earleywine (2011) ranged from .91 to .98.  
 Consequently, within the population of adults with a high level of ASD-related traits, 
several of the CESD-R items are not as highly correlated to the construct of depression as they 
are in a general population sample; however, the causal explanation for this difference remains 
unknown. For instance, it may be that there is a difference in the phenomenological experience 
of depression for those with ASD as compared to neurotypical individuals. Future research is 
needed to test this hypothesis explicitly.  
DASS-21 
 The hypothesis that the DASS-21 would not possess the same factor model specifications 
as established in general and clinical adult populations was not fully supported in the present 
study.  
 In the original paper of Lovibond and Lovibond (1995), principal components analysis 
was used to examine the psychometric properties of the DASS in a general sample of 717 
university students. In comparison to the principal components analysis (PCA) conducted by 
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Lovibond and Lovibond (1995), within the high ASD traits group, the DASS-21 demonstrated 
higher factor loadings for every item except one (“I was intolerant of anything that kept me from 
getting on with what I was doing”) in the present study. Specifically, for the Depression factor, 
standardized factor loadings ranged from .61 to .85 in the present study’s test of configural 
invariance, versus .45 to .80 in Lovibond and Lovibond’s (1995) PCA. Similarly, standardized 
factor loadings for the Anxiety factor in the present study ranged from .63 to .82 versus .47 to .64 
in the PCA of Lovibond and Lovibond (1995). Finally, standardized factor loadings for the 
Stress factor ranged from .67 to .75 in the present study versus .41 to .73 in Lovibond and 
Lovibond (1995). Overall, results indicated that items of the DASS-21 were more strongly 
related to the overarching constructs of anxiety, depression, and stress within the group of 
individuals with a high level of ASD-related traits than they were in the general population group 
sampled in the original DASS study.  
 Brown, Chorpita, Korotitsch, and Barlow (1997) examined the psychometric properties 
of the 42-item version of the DASS in a clinical sample of 241 patients presenting for assessment 
and treatment at an anxiety disorders clinic. In the confirmatory factor analysis conducted by 
Brown et al. (1997), factor loadings for the Depression factor ranged from .57 to .87; factor 
loadings for the Anxiety factor ranged from .45 to .80; and factor loadings for the Stress factor 
ranged from .60 to .79. Within the present study, factor loadings for all three factors in the high 
ASD traits group were within the ranges identified by Brown et al. (1997) or slightly higher (i.e., 
Anxiety factor: .63-.82). Importantly, given that the 21-item version of the DASS was used in the 
present study, these estimates are not fully comparable. In addition, because the DASS-21 has 
been found to have a cleaner factor structure as compared to the full DASS (Antony et al., 1998), 
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it is reasonable that the factor loadings in the present study would be somewhat higher, as the 
short form possesses better psychometrics.  
 Finally, Antony, Bieling, Cox, Enns, and Swinson (1998) examined the psychometric 
properties of the 42-item and 21-item versions of the DASS in a clinical sample of 258 adults 
seeking outpatient treatment for depression or anxiety disorders. In their PCA of the DASS-21, 
Antony et al. (1998) found factor loadings ranging from .55 to .91 for the Depression factor; .48 
to .82 for the Anxiety factor; and .52 to .84 for the Stress factor. In comparison, the high ASD 
traits group in the present study demonstrated similar factor loadings for the Depression factor 
(.61-.85), and similar factor loadings for the Anxiety (.63-.82) and Stress (.67-.75) factors, albeit 
that the range of scores was more restricted. Antony et al. (1998) emphasized that their findings 
provided support for the DASS being consistent with the tripartite model of anxiety and 
depression (Clark & Watson, 1991), in that scores on the Stress subscale were elevated across 
anxious and depressed groups, whereas Depression subscale scores were only elevated in the 
subgroup of individuals with depression. Importantly, however, further exploration of the DASS 
in relation to the tripartite model within the population of individuals with ASD is needed in 
order to determine whether the tripartite model would also be applicable to groups with ASD and 
comorbid psychiatric diagnoses.  
Hypothesis 3 
 Third, it was hypothesized that convergent validity would be demonstrated between the 
CESD-R and the Depression scale of the DASS-21, as evidenced by significant correlation 
coefficients. This hypothesis was supported in the present study. Specifically, within the overall 
sample of 433 adults, the CESD-R and the DASS-21 Depression scale demonstrated a 
significant, strong positive correlation (r = .86). 
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 This relationship held when looking at the two groups separately. For instance, within the 
low ASD traits group, there was a significant correlation of .89 between the CESD-R total score 
and the Depression scale of the DASS-21. Similarly, within the high ASD traits group, the 
CESD-R total score and the Depression scale of the DASS-21 were significantly correlated at r = 
.83. The similar correlations between the low ASD traits and high ASD traits groups support 
convergent validity of the CESD-R with the DASS-21 Depression scale irrespective of group 
membership, thus providing further confidence in the measurement of the construct of 
depression in those with and without ASD.  
Hypothesis 4 
 Finally, it was hypothesized that anxiety would be divergent from depression both within 
and between self-report measures among the low ASD traits group, but not within the high ASD 
traits group, given the potential for greater diagnostic overshadowing within ASD populations. 
This hypothesis was not supported in the present study. Contrary to the stated hypothesis, there 
were stronger correlations between depression and anxiety within the low ASD traits group as 
compared to the high ASD traits group. 
 Specifically, when examining the relationship between the DASS-21 Depression and 
Anxiety scales, there was a significant correlation of .78 in the low ASD traits group, and a 
significant correlation of .68 in the high ASD traits group. Similarly, the DASS-21 Anxiety scale 
and the CESD-R total score demonstrated a significant correlation of .80 in the low ASD traits 
group versus a significant correlation of .66 in the high ASD traits group. These higher 
correlations in the low ASD traits group as compared to the high ASD traits group run counter to 
hypotheses, indicating that the constructs of depression and anxiety may not be highly divergent 
even in individuals without ASD. Future research may wish to examine the DASS-21 and the 
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CESD-R in relation to other self-report measures of depression and anxiety to determine the 
extent to which these constructs are separable.  
 In addition, the relationship between the ASRS with both the CESD-R and the DASS-21 
was also examined for further evidence of discriminant validity. The ASRS Inattention scale and 
the DASS Anxiety scale demonstrated moderate positive correlations in both the low ASD traits 
(r = .57) and high ASD traits (r = .43) groups. The relationship was similar for the ASRS 
Inattention scale and self-report measures of depression. Specifically, the ASRS Inattention scale 
demonstrated a significant correlation of .58 with the DASS Depression scale in both the low 
ASD traits and high ASD traits groups. The ASRS Inattention scale was also moderately 
correlated with the CESD-R, with significant correlations of .57 in both groups.   
 The ASRS Hyperactivity-Impulsivity scale also demonstrated moderate correlations with 
anxiety and depression measures. For instance, it was correlated .62 with the DASS Anxiety 
scale in both the low ASD traits and high ASD traits groups. The ASRS Hyperactivity-
Impulsivity scale was moderately correlated with the CESD-R in the low ASD traits (r = .57) and 
high ASD traits groups (r = .63), as well as the DASS Depression scale (r = .58 in both groups).  
 Importantly, symptoms of anxiety and depression may overlap with those of ADHD. In 
particular, the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5; 
American Psychiatric Association, 2013) specifies “restlessness or feeling keyed up or on edge” 
as well as “difficulty concentrating or mind going blank” as symptoms associated with 
generalized anxiety disorder. Similarly, “psychomotor agitation or retardation nearly every day” 
and “diminished ability to think or concentrate, or indecisiveness, nearly every day” are listed as 
symptoms of major depressive disorder. Therefore, some overlap between ADHD and 
internalizing symptoms such as depression and anxiety is to be expected; however, the lack of 
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any strong positive correlations (i.e., r ≥ .70) between the ASRS and the CESD-R or DASS-21 
provides some evidence for the discriminability of ADHD symptoms from these constructs. 
Limitations 
 There are several limitations inherent to the present study. First, individuals were sorted 
into groups based upon their score on the AQ, rather than a clinically confirmed diagnosis of 
ASD. Although the AQ has utility in distinguishing individuals with clinically significant levels 
of ASD traits, with good discriminative validity and screening properties (Hurst et al., 2007; 
Woodbury-Smith et al., 2005), it is not a diagnostic instrument. Consequently, the present results 
are not directly generalizable to the population of individuals with and without confirmed autism 
diagnoses. As a result, it is unknown whether these results would replicate in a sample of 
individuals with confirmed autism diagnoses.  
 Secondly, the low and high ASD traits groups were created on the basis of a cut-off score 
of 26 on the AQ, in fitting with previous research by Woodbury-Smith et al. (2005) which 
demonstrated that this cut score correctly identified 83 percent of patients in a referred clinical 
sample. Although the results of Woodbury-Smith et al. (2005) provide acceptable support for 
sensitivity, their cut-off score of 26 is not perfectly sensitive in that it did not correctly identify 
100 percent of patients with ASD in the sample. Importantly, the use of a cut-off score may be 
flawed, in that there may not be a meaningful difference between those just above and just below 
the cut score. In the present study, those with an AQ score equal or above 26 were classified as 
the high ASD traits group; however, those with an AQ score of 25 may not be markedly different 
from those with an AQ score of 26 or 27. Indeed, there may be meaningful variation in ASD-
related traits that is not captured with the use of a cut-off score.  
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 A critical limitation of the present study concerns the use of the online platform Amazon 
Mechanical Turk. Although MTurk has several benefits, including the ability to collect a large 
sample at low cost (Horton & Chilton, 2010) and respondent anonymity which may result in 
greater comfort in disclosing psychiatric symptoms and mental health concerns (Shapiro, 
Chandler, & Mueller, 2013), it also has several notable disadvantages. Specifically, previous 
research regarding the use of MTurk to study clinical populations found a high proportion of 
respondents to endorse items consistent with malingering (Shapiro, Chandler, & Mueller, 2013), 
indicating that some participants may be exaggerating symptoms or faking distress. Further, 
because MTurk workers are free to select the tasks that they wish to perform among a variety of 
alternatives, there is an inherent selection bias that precludes collecting a fully representative 
sample. Other evidence indicates that MTurk samples are not fully representative of the general 
population. Indeed, according to the extant research literature, workers on MTurk tend to be 
younger, overeducated, and underemployed as compared to the larger population of Internet 
users and individuals in the general population (Paolacci, Chandler, & Ipeirotis, 2010). Of 
particular relevance to the present study, previous research has indicated that MTurk workers are 
more likely to possess traits associated with autism spectrum disorders (Mitchell & Locke, 
2015), with AQ scores observed within the MTurk population one-third of a standard deviation 
above those observed in a college student sample (Palmer, Paton, Enticott, & Hohwy, 2015). In 
the same vein, McCredie and Morey (2018) conducted a study of 455 MTurk workers using the 
Personality Assessment Inventory (PAI; Morey, 1991), and found that relative to a community 
sample, MTurk workers scored higher on the social detachment and depression scales. Given 
these results, it is likely that the present sample may not be fully representative of the general 
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population and may also be more likely to endorse higher levels of ASD-related traits and/or 
depression symptoms.  
 It is especially important to consider the extent to which MTurk is feasible as a tool for 
behavioral research. Previously, Crump, McDonnell, and Gureckis (2013) replicated a variety of 
experimental tasks using MTurk, including the Stroop (1935), Flanker (Ericksen & Ericksen, 
1974), Simon (Craft & Simon, 1970), and attentional blink (Shapiro, Raymond, & Arnell, 1997) 
tasks. Although Crump et al. (2013) found evidence for the validity of collecting experimental 
behavioral data via MTurk, they also found that testing participants’ comprehension of 
instructions was critical to robust data quality. In the present study, at least one attention check 
was included in each measure (e.g., “Please select ‘1-2 days’ for this question”). Additionally, 
participants were presented with an open-ended response for several of the demographic 
information questions (e.g., “How do you currently describe your gender identity?”; “What is 
your native language?”; “What is your age in years?”). Importantly, however, participants’ data 
were not removed unless it was clear that participants did not comprehend the questions (e.g., a 
participant answered “282019” when asked for their age in years) or failed all four attention 
checks. Subsequently, the lack of explicit feedback regarding survey instructions may have 
hindered some participants’ comprehension of survey items.  
 Finally, the present study is necessarily limited by its examination of a singular 
population of interest: in this case, adults with and without a high level of ASD-related traits. As 
such, other important constructs of interest were not examined. For instance, it is unknown to 
what extent the study measures would demonstrate invariance with regard to age, ethnicity, or 
other important factors. Future research would do well to investigate the invariance of these 




 There are several clinical and research implications inherent to the results of the present 
study. Simply, and perhaps most notably, the finding of significantly higher scores on the CESD-
R, DASS-21, and ASRS within the high ASD traits group provides further support for the idea 
that individuals with ASD experience higher levels of psychopathology as compared to 
individuals without ASD (Brereton et al., 2006; Hudson et al., 2018; Roy et al., 2015), with 
ADHD, anxiety, and depression being the most common comorbidities in adults with ASD 
(Lever & Geurts, 2016). These findings highlight the need for further research into the 
assessment and treatment of such conditions within this population, as well as any necessary 
modifications to adapt existing measures and interventions to the unique needs of those with 
ASD.  
 In particular, the finding of a lack of the most basic level of factorial invariance for the 
CESD-R indicates that its factor model specification is not equivalent across adults with and 
without a high level of ASD-related traits. Although the CESD-R was designed to be a valid 
assessment of depression symptoms in epidemiological and community-based samples (Eaton et 
al., 2004), it appears that it does not capture symptoms of depression in those with ASD in the 
same way as compared to those who are neurotypical. Consequently, the lack of evidence for 
factorial invariance suggests that the CESD-R may not be an ideal tool for assessment of 
depression, at least as the construct is currently understood, for adults with a high level of ASD-
related traits.  
 The finding of scalar invariance across the two groups for the DASS-21 provides 
evidence for cross-group equality in factor loadings and factor intercepts. In other words, scalar 
invariance indicates that there are similar latent means and factor relationships on the DASS-21 
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for those with high and low levels of ASD-related traits, such that any differences in the means 
and covariances of DASS-21 items are due to differences in the latent parameters. These findings 
provide support that the DASS-21 is operating similarly in individuals with and without a high 
level of ASD-related traits. Thus, clinicians and researchers can have confidence that the DASS-
21 is measuring symptoms of depression, anxiety, and stress similarly and accurately across 
those with and without a high level of ASD-related traits.  
 Multigroup factorial invariance analyses of the ASRS provided support for metric 
invariance of the measure, indicating that the same latent constructs are being measured across 
individuals with high and low levels of ASD-related traits. At the same time, the lack of evidence 
for scalar invariance across groups suggests that there are different factor relationships, latent 
means, and observed error variances for those with high and low levels of ASD-related traits. In 
this case, when using the ASRS in those with a high level of ASD traits, one can assume to 
adequately measure the latent constructs of inattention and hyperactivity-impulsivity. 
Conversely, however, one cannot assume that the levels and relationships among the constructs 
of inattention and hyperactivity-impulsivity will be the same in those with a high level of ASD 
traits. In this sense, clinicians should proceed with caution when using the ASRS to assess 
symptoms of ADHD in those with ASD. 
 Finally, the finding of stronger correlations between measures of depression and anxiety 
within the low ASD traits group as compared to the high ASD traits group provides evidence that 
these constructs may be relatively more distinct in those with a high level of ASD traits. The 
reason for this finding is unknown, but it is possible that those with ASD experience depression 
and anxiety in a way that is qualitatively different from neurotypical individuals and is not 
adequately captured by items on either the CESD-R or the DASS-21. Future research may wish 
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to explore additional behavioral and cognitive signs of anxiety and depression that may be 
unique to those with ASD.    
Conclusions 
 Individuals with ASD experience internalizing symptoms, including depression and 
anxiety, at a higher rate than do individuals without ASD (Buck et al., 2014; Cassidy et al., 2014; 
Joshi et al., 2013). Although the extant literature indicates that depression and anxiety are highly 
prevalent in the ASD population, research on the psychometric properties of commonly used 
self-report measures of depression and anxiety within this population is limited. Importantly, 
because most measures of anxiety and depression have not been normed with individuals with 
ASD, one cannot assume that these measures reliably or validly assess these constructs in people 
with ASD.  
 The current study sought to examine the factor structures of the DASS-21 and the CESD-
R in individuals with a high and low level of ASD-related traits as measured by the AQ. It also 
examined convergent and discriminant validity of these measures. This was one of the first 
studies to examine factorial invariance of the DASS-21 and the CESD-R in individuals with and 
without a high level of ASD traits. Results suggest that the DASS-21 and the CESD-R are not 
fully invariant across those with and without a high level of ASD traits, such that scores on these 
measures include some degree of measurement bias. As a result, the DASS-21 and the CESD-R 
should be interpreted with caution when assessing symptoms of depression and anxiety in those 
with ASD. The present analyses provide support for the idea that an alternative assessment is 






Demographic Characteristics of Low and High ASD Trait Groups 
Variable Low ASD Traits 
Sample Mean (SD) 
High ASD Traits 
Sample Mean (SD) 
Between-group 
difference p value 
Age 
 
36.08 (11.67) 34.81 (10.12) .301a 
CESD-R Total 11.36 (14.11) 
 
20.27 (16.79)  < .001a 
AQ Total 17.39 (5.82) 
 
29.18 (3.56)  < .001a 
DASS_Depression 3.82 (5.08) 
 
6.71 (5.70)  < .001a 
DASS_Anxiety 2.60 (3.95) 
 
5.19 (5.05)  < .001a 
DASS_Stress 3.81 (4.6) 
 
7.13 (5.1)  < .001a 
ASRS_Inattention 10.78 (7.4) 
 
14.00 (7.3)  < .001a 
ASRS_Hyperactivity 8.93 (6.36) 
 
12.32 (6.78)  < .001a 
Note. aMann-Whitney U test. 
Variable Low ASD 
Traits Sample 
(n = 203) 
High ASD  
Traits Sample  
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Bivariate Correlations among ASRS Items, Low ASD Traits Group 
Variable 1. 2. 3. 4. 5. 6. 7. 8. 9. 10. 11. 12. 13. 14. 15. 16. 17. 18.  
1. 1.0                  
2. .65 1.0                 
3. .63 .62 1.0                
4. .62 .61 .57 1.0               
5. .51 .57 .55 .56 1.0              
6. .41 .54 .48 .55 .61 1.0             
7. .49 .57 .50 .51 .55 .61 1.0            
8. .53 .61 .59 .51 .53 .46 .54 1.0           
9. .55 .53 .48 .60 .50 .60 .55 .50 1.0          
10. .35 .42 .43 .46 .40 .49 .49 .43 .49 1.0         
11. .37 .33 .30 .33 .36 .28 .41 .28 .32 .43 1.0        
12. .38 .44 .49 .33 .53 .37 .49 .48 .33 .36 .32 1.0       
13. .46 .48 .41 .47 .45 .53 .49 .52 .47 .71 .52 .40 1.0      
56 
 
14. .45 .50 .42 .42 .45 .45 .43 .39 .51 .38 .41 .49 .51 1.0     
15. .39 .43 .34 .42 .54 .38 .52 .40 .42 .35 .43 .46 .35 .39 1.0    
16. .33 .33 .30 .36 .38 .33 .50 .31 .37 .38 .38 .30 .39 .24 .56 1.0   
17. .46 .52 .55 .40 .50 .34 .55 .49 .42 .42 .34 .56 .43 .37 .58 .49 1.0  
18. .27 .40 .30 .29 .54 .34 .51 .42 .40 .42 .26 .49 .37 .38 .53 .57 .60 1.0 






Bivariate Correlations among ASRS Items, High ASD Traits Group 
Variable 1. 2. 3. 4. 5. 6. 7. 8. 9. 10. 11. 12. 13. 14. 15. 16. 17. 18. 
1. 1.0                  
2. .54*** 1.0                 
3. .43*** .56*** 1.0                
4. .38*** .46*** .37*** 1.0               
5. .38*** .46*** .36*** .46*** 1.0              
6. .50*** .44*** .36*** .51*** .47*** 1.0             
7. .35*** .36*** .37*** .48*** .49*** .51*** 1.0            
8. .34*** .48*** .40*** .35*** .43*** .38*** .32*** 1.0           
9. .36*** .41*** .40*** .41*** .45*** .48*** .44*** .37*** 1.0          
10. .37*** .35*** .37*** .36*** .31*** .47*** .36*** .38*** .44*** 1.0         
11. .22** .21** .24*** .23*** .32*** .30*** .41*** .25*** .35*** .42*** 1.0        
12. .39*** .52*** .35*** .19** .36*** .30*** .31*** .46*** .32*** .34*** .39*** 1.0       
13. .25*** .31*** .28*** .24*** .36*** .41*** .37*** .31*** .41*** .59*** .40*** .30*** 1.0      
14. .35*** .35*** .31*** .23** .25*** .42*** .35*** .28*** .42*** .42*** .33*** .32*** .41*** 1.0     
15. .33*** .24*** .29*** .13 .29*** .24*** .18** .36*** .34*** .15* .26*** .44*** .20** .23** 1.0    
16. .25*** .27*** .18** .18** .45*** .21** .13 .26*** .27*** .09 .23** .37*** .19** .13 .45*** 1.0   
17. .33*** .35*** .32*** .17* .48*** .28*** .16** .30*** .33*** .19** .24*** .44*** .27*** .26*** .50*** .55*** 1.0  
18. .33*** .37*** .31*** .18** .40*** .34*** .27*** .29*** .37*** .17* .27*** .41*** .17** .31*** .40*** .44*** .59*** 1.0 




Bivariate Correlations among DASS-21 Items, Low ASD Traits Group 
Variable 1. 2. 3. 4. 5. 6. 7. 8. 9. 10. 11. 12. 13. 14. 15. 16. 17. 18. 19. 20. 21. 
1. 1.0                     
2. .59 1.0                    
3. .75 .63 1.0                   
4. .73 .59 .72 1.0                  
5. .75 .65 .75 .70 1.0                 
6. .72 .61 .72 .75 .68 1.0                
7. .74 .57 .76 .67 .70 .77 1.0               
8. .48 .47 .39 .34 .51 .35 .37 1.0              
9. .48 .44 .45 .44 .41 .46 .42 .45 1.0             
10. .62 .51 .57 .60 .52 .53 .53 .42 .53 1.0            
11. .60 .56 .55 .60 .61 .63 .58 .46 .52 .50 1.0           
12. .54 .49 .50 .53 .59 .55 .51 .52 .57 .59 .58 1.0          
13. .58 .55 .55 .60 .61 .54 .55 .52 .65 .61 .60 .76 1.0         
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14. .64 .57 .68 .62 .66 .65 .65 .49 .62 .66 .65 .66 .66 1.0        
15. .47 .54 .51 .44 .55 .49 .44 .40 .40 .47 .50 .54 .49 .51 1.0       
16. .65 .57 .69 .59 .65 .62 .62 .47 .45 .53 .48 .54 .56 .58 .54 1.0      
17. .64 .57 .60 .57 .61 .62 .57 .40 .57 .57 .63 .57 .63 .62 .56 .66 1.0     
18. .59 .62 .60 .64 .60 .62 .57 .45 .53 .55 .64 .62 .65 .58 .56 .67 .63 1.0    
19. .54 .54 .57 .59 .65 .61 .55 .43 .37 .48 .62 .61 .53 .58 .66 .54 .57 .60 1.0   
20. .60 .52 .64 .58 .64 .57 .61 .44 .39 .55 .53 .58 .57 .60 .50 .65 .54 .67 .55 1.0  
21. .57 .53 .53 .61 .59 .64 .47 .46 .52 .55 .64 .61 .61 .63 .53 .61 .61 .74 .59 .64 1.0 













Bivariate Correlations among DASS-21 Items, High ASD Traits Group 
Variable 1. 2. 3. 4. 5. 6. 7. 8. 9. 10. 11. 12. 13. 14. 15. 16. 17. 18. 19. 20. 21. 
1. 1.0                     
2. .55 1.0                    
3. .66 .49 1.0                   
4. .65 .47 .72 1.0                  
5. .63 .51 .55 .61 1.0                 
6. .57 .48 .73 .67 .58 1.0                
7. .61 .41 .71 .66 .61 .71 1.0               
8. .38 .40 .40 .35 .45 .41 .37 1.0              
9. .46 .36 .42 .43 .41 .41 .41 .54 1.0             
10. .46 .35 .36 .37 .43 .40 .43 .49 .59 1.0            
11. .39 .47 .45 .50 .42 .47 .41 .45 .45 .44 1.0           
12. .51 .40 .51 .55 .48 .45 .49 .44 .57 .62 .61 1.0          
13. .45 .44 .43 .48 .46 .45 .40 .46 .59 .62 .51 .62 1.0         
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14. .47 .40 .43 .42 .49 .45 .40 .49 .52 .51 .56 .64 .59 1.0        
15. .49 .48 .48 .54 .45 .47 .46 .42 .38 .41 .50 .49 .46 .40 1.0       
16. .57 .50 .49 .45 .58 .48 .50 .42 .45 .45 .51 .48 .34 .54 .47 1.0      
17. .41 .43 .47 .49 .43 .46 .41 .46 .45 .50 .61 .63 .58 .49 .46 .44 1.0     
18. .45 .48 .50 .50 .49 .46 .45 .33 .39 .38 .51 .51 .48 .47 .52 .56 .48 1.0    
19. .47 .50 .47 .51 .53 .44 .48 .45 .39 .42 .51 .58 .43 .46 .67 .49 .56 .53 1.0   
20. .45 .41 .46 .49 .53 .49 .51 .35 .31 .31 .44 .40 .40 .38 .41 .52 .35 .55 .41 1.0  
21. .55 .51 .54 .54 .54 .56 .52 .34 .37 .38 .50 .42 .46 .46 .49 .57 .42 .63 .44 .61 1.0 




Table 6  
Bivariate Correlations among CESD-R Items, Low ASD Traits Group 
Variable 1. 2. 3. 4. 5. 6. 7. 8. 9. 10. 11. 12. 13. 14. 15. 16. 17. 18. 19. 20. 
1. 1.0                    
2. .82 1.0                   
3. .79 .88 1.0                  
4. .73 .73 .69 1.0                 
5. .66 .69 .70 .73 1.0                
6. .39 .38 .45 .36 .44 1.0               
7. .39 .29 .41 .46 .42 .57 1.0              
8. .56 .51 .49 .54 .50 .33 .29 1.0             
9. .41 .43 .46 .42 .52 .56 .48 .26 1.0            
10. .49 .50 .44 .44 .48 .30 .25 .77 .33 1.0           
11. .62 .67 .69 .71 .67 .45 .48 .39 .52 .39 1.0          
12. .73 .75 .77 .75 .68 .39 .45 .40 .42 .37 .71 1.0         
13. .63 .67 .61 .61 .65 .32 .25 .60 .46 .59 .58 .48 1.0        
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14. .61 .61 .65 .61 .62 .39 .38 .66 .36 .57 .54 .62 .66 1.0       
15. .53 .46 .49 .50 .53 .48 .51 .40 .46 .23 .52 .48 .40 .46 1.0      
16. .60 .61 .66 .66 .64 .42 .46 .50 .36 .41 .61 .67 .50 .57 .57 1.0     
17. .68 .65 .67 .63 .71 .40 .47 .54 .42 .51 .64 .63 .68 .63 .52 .62 1.0    
18. .59 .60 .64 .66 .74 .49 .49 .51 .53 .49 .70 .68 .70 .63 .55 .63 .76 1.0   
19. .50 .48 .56 .57 .43 .27 .46 .35 .24 .18 .48 .51 .23 .36 .40 .57 .33 .32 1.0  
20. .36 .51 .55 .46 .52 .48 .47 .27 .41 .28 .62 .50 .37 .38 .38 .54 .53 .47 .42 1.0 





Bivariate Correlations among CESD-R Items, High ASD Traits Group 
Variable 1. 2. 3. 4. 5. 6. 7. 8. 9. 10. 11. 12. 13. 14. 15. 16. 17. 18. 19. 20. 
1. 1.0                    
2. .75*** 1.0                   
3. .76*** .80*** 1.0                  
4. .70*** .68*** .69*** 1.0                 
5. .69*** .62*** .66*** .67*** 1.0                
6. .43*** .40*** .45*** .37*** .52*** 1.0               
7. .26*** .20** .19* .27*** .27*** .47*** 1.0              
8. .49*** .48*** .55*** .51*** .55*** .45*** .2** 1.0             
9. .43*** .41*** .41*** .37*** .48*** .46*** .45*** .30*** 1.0            
10. .44*** .52*** .50*** .47*** .47*** .38*** .13* .73*** .29*** 1.0           
11. .62*** .64*** .65*** .67*** .63*** .37*** .35*** .46*** .38*** .44*** 1.0          
12. .69*** .71*** .67*** .66*** .69*** .44*** .30*** .49** .43*** .49*** .71*** 1.0         
13. .58*** .56*** .53*** .56*** .62*** .43*** .21** .53*** .46*** .43*** .49*** .56*** 1.0        
14. .38*** .49*** .49*** .48*** .48*** .34*** .05 .51*** .35*** .50*** .35*** .50*** .60*** 1.0       
15. .47*** .50*** .46*** .47*** .53*** .39*** .39*** .41*** .51*** .42*** .50*** .59*** .49*** .45*** 1.0      
16. .26*** .35*** .37*** .31*** .36*** .31*** .23** .46*** .23** .48*** .44*** .37*** .34*** .31*** .38*** 1.0     
17. .55*** .59*** .56*** .45*** .54*** .41*** .15* .47*** .40*** .47*** .48*** .50*** .59*** .44*** .42*** .36*** 1.0    
18. .58*** .63*** .61*** .56*** .64*** .41*** .26*** .55*** .43*** .50*** .61*** .66*** .67*** .49*** .62*** .50*** .72*** 1.0   
19. .46*** .50*** .45*** .45*** .47*** .27*** .53*** .29*** .53*** .34*** .56*** .53*** .34*** .24** .46*** .24** .35*** .47*** 1.0  
20. .34*** .38*** .37*** .44*** .37*** .30*** .59*** .17** .42*** .31*** .48*** .49*** .28*** .19** .47*** .27*** .22** .37*** .72*** 1.0 





Skewness and Kurtosis Statistics for Items 
Variable Skewness  Kurtosis  
AQ1 -.27  -1.94  
AQ2 -.45 -1.81 
AQ3 1.46 .14 
AQ4 -.55 -1.70 
AQ5 -.64 -1.60 
AQ6 -.27 -1.94 
AQ7 .82 -1.34 
AQ8 1.46 .14 
AQ9 .46 -1.79 
AQ10 .41 -1.84 
AQ11 -.34 -1.89 
AQ12 -1.12 -.75 
AQ13 -.52 -1.74 
AQ14 .13 -1.99 
AQ15 -.12 -.75 
AQ16 -.44 -1.81 
AQ17 .41 -1.83 
AQ18 .74 -1.47 
AQ19 -.11 -1.99 
AQ20 1.01 -.98 
AQ21 .94 -1.13 
AQ22 -.40 -1.85 
AQ23 -.71 -1.50 
AQ24 -.07 -2.00 
AQ25 -.61 -1.64 
AQ26 -.31 -1.92 
AQ27 .96 -1.08 
AQ28 .17 -1.98 
AQ29 .24 -1.95 
AQ30 -.51 -1.75 
AQ31 1.33 -.24 
AQ32 .41 -1.84 
AQ33 .33 -1.90 
AQ34 -.005 -2.00 
AQ35 .77 -1.42 
AQ36 .89 -1.20 
AQ37 .61 -1.64 
AQ38 -.29 -1.93 
AQ39 .58 -1.67 
AQ40 .82 -1.34 
AQ41 -.04 -2.00 
AQ42 .15 -1.99 
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AQ43 -1.46 .14 
AQ44 -.04 -2.00 
AQ45 .63 -1.62 
AQ46 -.91 -1.18 
AQ47 -.03 -2.00 
AQ48 .58 -1.67 
AQ49 .30 -1.92 
AQ50 .52 -1.74 
DASS-1 .82 -.20 
DASS-2 1.15 .42 
DASS-3 1.00 .009 
DASS-4 1.54 1.58 
DASS-5 .83 -.25 
DASS-6 .89 -.23 
DASS-7 1.69 1.97 
DASS-8 .88 -.38 
DASS-9 1.07 .029 
DASS-10 .87 -.49 
DASS-11 .74 -.45 
DASS-12 .80 -.44 
DASS-13 .80 -.53 
DASS-14 .97 .03 
DASS-15 1.29 .53 
DASS-16 .95 -.23 
DASS-17 1.04 -.15 
DASS-18 .83 -.27 
DASS-19 1.19 .30 
DASS-20 1.36 .83 
DASS-21 1.26 .46 
ASRS-1 .47 -.27 
ASRS-2 .52 -.37 
ASRS-3 .63 -.35 
ASRS-4 .30 -.69 
ASRS-5 .39 -.87 
ASRS-6 .54 -.48 
ASRS-7 .57 -.14 
ASRS-8 .19 -.65 
ASRS-9 .63 -.34 
ASRS-10 .35 -.57 
ASRS-11 .30 -.59 
ASRS-12 1.09 .45 
ASRS-13 .56 -.27 
ASRS-14 .35 -.56 
ASRS-15 .81 .03 
ASRS-16 .76 -.17 
ASRS-17 .77 -.16 
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ASRS-18 .68 .13 
CESD-R-1 1.63 2.20 
CESD-R-2 1.23 .54 
CESD-R-3 1.08 .43 
CESD-R-4. 1.11 .16 
CESD-R-5 .76 -.52 
CESD-R-6 1.12 .24 
CESD-R-7 1.15 .48 
CESD-R-8 1.35 .96 
CESD-R-9 1.43 1.08 
CESD-R-10 1.26 .76 
CESD-R-11 1.50 1.70 
CESD-R-12 1.48 1.24 
CESD-R-13 1.33 .79 
CESD-R-14 2.26 4.64 
CESD-R-15 2.75 7.81 
CESD-R-16 .98 -.14 
CESD-R-17 1.1 -.03 
CESD-R-18 2.44 5.40 
CESD-R-19 1.02 -.10 
CESD-R-20 .97 -.03 




Bivariate Correlations between Subscale Scores on Study Measures 
 Low ASD Traits (n = 203)  High ASD Traits (n =220) 
Measure 1. 2.  3.  4.  5. 6.  1. 2. 3. 4. 5.  6. 
1. CESD-R 1.0 
 
      1.0      




1.0      .83 1.0     
3. DASS-
Anxiety 
.80 .78 1.0     .66 .68 1.0    
4. DASS-Stress .82 .84 .83 1.0    .77 .80 .77 1.0   
5. ASRS - 
Inattention 
.57 .58 .57 .62 1.0   .57 .58 .43 .56 1.0  
6. ASRS – 
Hyperactivity 
Impulsivity 
.57 .58 .62 .67 .77 1.0  .63 .58 .62 .67 .75 1.0 





Internal Consistency of Study Measures 
Measure Total Sample  
(n = 422 - 424) 
 Low ASD Traits  
(n = 202- 203) 
 High ASD Traits  
(n = 220 -221) 
      
CESD-R .953 
 
 .955  .944 
DASS-21 .962 
 
 .966  .95 
DASS – 
Depression 
.931  .94  .913 
DASS – 
Anxiety 
.905  .904  .891 
DASS – 
Stress 
.906  .915  .875 
ASRS – 
Total 
.927  .936  .903 
ASRS – 
Inattention 




.853  .87  .813 





Goodness of Fit Indices for Alternative Confirmatory Factor Analysis Models 
Measure Model Χ2 df p RMSEA 
[90% CI] 
CFI SRMR TLI AIC BIC 
 
CESD-R 
Configural 949.14 338 < .001  .092 
[.085, .099] 
.808 .077 .785 20145.31 20252.23 
Metric 978.45 357 < .001 .091 
[.084, .097] 
.805 .086 .793 20150.28 20240.55 
 
DASS-21 
Configural 527.06 373 < .001 .04 
[.035, .053] 
.954 .229 .949 16959.46 17073.65 
Metric 539.86 388 < .001 .043 
[.034, .051] 
.955 .228 .951 16943.67 17044.78 
Scalar 560.47 406 < .001 .042 
[.034, .051] 
.954 .229 .953 16927.02 17012.44 
 Strict 761.68 427 < .001 .061 
[.054, .068] 
.901 .230 .903 17246.68 17313.79 
 
ASRS 
Configural 672.44 268 < .001 .084 
[.077, .092] 
.849 .108 .827 19752.64 19848.79 
Metric 687.47 282 < .001 .082 
[.075, .09] 
.848 .110 .84 19735.93 19819.84 
Scalar 720.08 298 < .001 .082 
[.074, .089] 
.842 .110 .84 19735.49 19805.42 
 Strict 807.66 316 < .001 .086 
[.078, .093] 
.816 .116 .822 19808.46 19862.65 
71 
 
Note. RMSEA = root mean square error of approximation; CFI = comparative fit index; SRMR = standardized root mean square 





Results of Exploratory Factor Analysis of the CESD-R 










My appetite was poor. -.021 .505 .323 .359 
I could not shake off 
the blues. 
.865 .050 -.150 .773 
I had trouble keeping 
my mind on what I 
was doing. 
.130 .673 -.003 .469 
I felt depressed. .997 -.021 -.236 1.04 
My sleep was restless. -.227 .950 -.004 .954 
I felt sad. .928 .022 -.183 .895 
I could not get going. .031 .784 -.034 .616 
Nothing made me 
happy.  
.730 .121 -.025 .548 
I felt like a bad person. .597 .175 .143 .407 
73 
 
I lost interest in my 
usual activities. 
.362 .474 .066 .360 
I slept much more than 
usual.  
.045 .416 .375 .315 
I felt like I was 
moving too slowly. 
.031 .542 .346 .414 
I felt fidgety. .026 .572 .156 .352 
I wished I were dead. .674 -.179 .353 .610 
I wanted to hurt 
myself. 
.377 .008 .531 .424 
I was tired all the time. -.024 .775 -.059 .604 
I did not like myself. .743 .114 .026 .565 
I lost a lot of weight 
without trying to. 
-.016 .220 .711 .554 
I had a lot of trouble 
getting to sleep. 
-.187 .862 -.002 .778 
I could not focus on 
the important things. 
.010 .789 .156 .646 
     
Eigenvalues 10.681 1.606 1.140  
74 
 
Correlations among factors 
 1 2 3  
1 -    
2 .825 -   
3 .383 .193 -  






Figure 1a. Unstandardized parameter estimates for configural invariance of the CESD-R. Estimates for the high ASD traits cohort are 




Figure 1b. Unstandardized parameter estimates for metric invariance of the CESD-R. Factor loadings were constrained to be equal 






Figure 2a. Unstandardized parameter estimates for configural invariance of the DASS-21. Estimates for the high ASD traits cohort are 






Figure 2b. Unstandardized parameter estimates for metric invariance of the DASS-21. Factor loadings were constrained to be equal 




Figure 2c. Unstandardized parameter estimates for scalar invariance of the DASS-21. Factor loadings and intercepts were constrained 
to be equal across groups. Estimates for the high ASD traits cohort are presented in boldface following estimates for the low ASD 





Figure 2d. Unstandardized parameter estimates for strict invariance of the DASS-21. Factor loadings, intercepts, and residual 
variances were constrained to be equal across groups. Estimates for the high ASD traits cohort are presented in boldface following 






Figure 3a. Unstandardized parameter estimates for configural invariance of the ASRS. Estimates for the high ASD traits cohort are 






Figure 3b. Unstandardized parameter estimates for metric invariance of the ASRS. Factor loadings were constrained to be equal 





Figure 3c. Unstandardized parameter estimates for scalar invariance of the ASRS. Factor loadings and intercepts were constrained to 







Figure 3d. Unstandardized parameter estimates for strict invariance of the ASRS. Factor loadings, intercepts, and residual variances 
were constrained to be equal across groups. Estimates for the high ASD traits cohort are presented in boldface following estimates for 
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